Processing 00000000.tx.1: Identification of iduronate-2-sulfatase in mouse pancreatic islets I. 

Phrase: "Identification of iduronate-2-sulfatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in mouse pancreatic islets I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C1522528:Mouse Islets [Tissue]
Processing 00000000.tx.2: Coronado-Pons,1 A. 

Phrase: "Coronado-Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0032639:Pons [Body Part, Organ, or Organ Component]
   861   C1280999:Pons [Body Part, Organ, or Organ Component]
   827 E C1418754:PON [Gene or Genome]
   827 E C1709588:PON [Mammal]

Phrase: "1 A."
Processing 00000000.tx.3: Novials,2 S. 

Phrase: "Novials,"

Phrase: "2 S."
Processing 00000000.tx.4: Casas,1,2 A. 

Phrase: "Casas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1384511:CASA [Gene or Genome]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2 A."
Processing 00000000.tx.5: Clark,3 and R. 

Phrase: "Clark,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.6: Gomis1 1Endocrinology and Diabetes Unit, Laboratory of Experimental Diabetes, Institut d'Investigacions Biomdiques August Pi i Sunyer, Hospital Clnic de Barcelona, Barcelona University; 

Phrase: "Gomis1 1Endocrinology"

Phrase: "and"

Phrase: "Diabetes Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Laboratory of Experimental Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Institut"

Phrase: "d'"

Phrase: "Investigacions Biomdiques August Pi i Sunyer,"

Phrase: "Hospital Clnic de Barcelona,"

Phrase: "Barcelona University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ";"
Processing 00000000.tx.7: 2Institute of Diabetes, Fundaci Sard Farriol, Barcelona, Spain; 

Phrase: "2Institute of Diabetes,"

Phrase: "Fundaci Sard Farriol,"

Phrase: "Barcelona,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: ";"
Processing 00000000.tx.8: and 3Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, United Kingdom Submitted 20 November 2003 ; accepted in final form 11 May 2004  ABSTRACT TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  The lysosomal enzyme iduronate-2-sulfatase (IDS) is expressed in pancreatic islets and is responsible for degradation of proteoglycans, such as perlecan and dermatan sulfate. 

Phrase: "and"

Phrase: "3Diabetes Research Laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   867   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Oxford Centre for Diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "Endocrinology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Churchill Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Oxford,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "20 November 2003"

Phrase: ";"

Phrase: "accepted in final form 11 May 2004  ABSTRACT TOP ABSTRACT MATERIALS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   738   C0000857:Abstract [Occupational Activity]
   738   C0205088:Final [Temporal Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0520510:Materials [Substance]
   738   C0600678:Abstract [Intellectual Product]
   738   C1272684:Accepted [Qualitative Concept]
   738   C1522492:Form [Functional Concept]
   738   C1546485:Final [Idea or Concept]
   738   C1548435:Accepted [Idea or Concept]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   704 E C1548601:Accept [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The lysosomal enzyme iduronate-2-sulfatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   884   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   804   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IDS)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "expressed in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "is"

Phrase: "responsible for degradation of proteoglycans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "such as perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "dermatan sulfate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011602:Dermatan Sulfate [Biologically Active Substance,Carbohydrate]
           Dermatan
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.9: To determine the role of IDS in islets, expression and regulation of the gene and localization of the enzyme were investigated in mouse pancreatic islets and clonal cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of IDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in islets,"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "regulation of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0017263:Gene Regulation [Genetic Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "localization of the enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "were"

Phrase: "investigated in mouse pancreatic islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   797   C1522528:Mouse Islets [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C1292732:investigated [Functional Concept]

Phrase: "and"

Phrase: "clonal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   964   C0009013:Clone Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: The Ids gene was expressed in mouse islets and - and -clonal cells, in which it was localized intracellularly in lysosomes. 

Phrase: "The Ids gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017337:Gene [Gene or Genome]
   756   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   756   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]

Phrase: "was"

Phrase: "expressed in mouse islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1522528:Mouse Islets [Tissue]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]

Phrase: "and -"

Phrase: "and -"

Phrase: "clonal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   964   C0009013:Clone Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in which"

Phrase: "it"

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "intracellularly in lysosomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0024369:Lysosomes [Cell Component]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]
Processing 00000000.tx.11: The transcriptional expression of Ids in mouse islets increased with glucose in a dose-dependent manner (11.5, 40.2, 88, and 179% at 5.5, 11.1, 16.7, and 24.4 mM, respectively, P < 0.01 for 16.7 and 24.4 mM glucose vs. 3 mM glucose). 

Phrase: "The transcriptional expression of Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "increased with glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   858   C0860803:glucose increased [Finding]
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(11.5,"

Phrase: "40.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "88,"

Phrase: "and"

Phrase: "179% at 5.5,"

Phrase: "11.1,"

Phrase: "16.7,"

Phrase: "and"

Phrase: "24.4 mM,"

Phrase: "respectively,"

Phrase: "P < 0.01 for 16.7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "24.4 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "vs. 3 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.12: This increase was not produced by glyceraldehyde (1 mM) or 6-deoxyglucose (21.4 mM) and was blocked by the addition of mannoheptulose (21.4 mM). 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produced by glyceraldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017854:Glyceraldehyde [Carbohydrate]

Phrase: "(1 mM)"

Phrase: "or"

Phrase: "6-deoxyglucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049551:6-deoxyglucose [Carbohydrate]
   861   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "(21.4 mM)"

Phrase: "and"

Phrase: "was"

Phrase: "blocked by the addition of mannoheptulose"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0024735:Mannoheptulose [Carbohydrate]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C1883712:Addition [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(21.4 mM"

Phrase: ")."
Processing 00000000.tx.13: Neither insulin content nor secretory response to glucose (16.7 mM) was altered in mouse islets infected with lentiviral constructs carrying the IDS gene in sense orientation. 

Phrase: "Neither insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "nor"

Phrase: "secretory response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "(16.7 mM)"

Phrase: "was"

Phrase: "altered in mouse islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1522528:Mouse Islets [Tissue]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0392747:Altered [Functional Concept]

Phrase: "infected with lentiviral constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439663:Infected [Functional Concept]
   737   C2827421:Construct [Classification]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the IDS gene in sense orientation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1415882:IDS gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.14: Furthermore, no decrease in islet cell viability was observed in mouse islets carrying lentiviral contracts compared with controls. 

Phrase: "Furthermore,"

Phrase: "no decrease in islet cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in mouse islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1522528:Mouse Islets [Tissue]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1441672:Observed [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "lentiviral contracts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332522:Contracts [Intellectual Product]
   827 E C1705564:Contract [Conceptual Entity]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.15: However, insulin content was reduced (35% vs. controls, P < 0.001) in islets infected with IDS antisense construct, while the secretory response of those islets to glucose was maintained. 

Phrase: "However,"

Phrase: "insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(35%"

Phrase: "vs. controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in islets"

Phrase: "infected with IDS antisense construct,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439663:Infected [Functional Concept]
   760   C2827421:Construct [Classification]

Phrase: "while"

Phrase: "the secretory response of those islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "maintained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]
Processing 00000000.tx.16: Inhibition of IDS by antisense infection led to an increase in lysosomal size and a high rate of insulin granule degradation via the crinophagic route in pancreatic -cells. 

Phrase: "Inhibition of IDS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by antisense infection"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "led to an increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in lysosomal size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "a high rate of insulin granule degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0020459:high insulin [Disease or Syndrome]
   748   C0205250:High [Qualitative Concept]
   748   C0871208:Rate [Activity]
   748   C1299351:High [Qualitative Concept]
   748   C1521828:Rate [Quantitative Concept]
   748   C2700149:HIGH [Intellectual Product]

Phrase: "via the crinophagic route"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013153:ROUTE [Functional Concept]
   861   C0449444:Route [Spatial Concept]
   861   C1879941:ROUTE [Intellectual Product]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.17: We conclude that IDS is localized in lysosomes in pancreatic islet cells and expression is regulated by glucose. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "localized in lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C0392752:Localized [Spatial Concept]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "in pancreatic islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.18: IDS has a potential role in the normal pathway of lysosomal degradation of secretory peptides and is likely to be essential to maintain pancreatic -cell function. perlecan; 

Phrase: "IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "a potential role in the normal pathway of lysosomal degradation of secretory peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0035820:Role [Social Behavior]
   735   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "essential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205224:Essential [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "pancreatic -cell function. perlecan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0136134:perlecan [Amino Acid, Peptide, or Protein]
   812   C1415793:PERLECAN [Gene or Genome]
   812   C2987155:Perlecan [Amino Acid, Peptide, or Protein]
   708   C0232786:Pancreatic function [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.19: islet amyloid polypeptide; 

Phrase: "islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.20: insulin content and secretion; 

Phrase: "insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: ";"
Processing 00000000.tx.21: lysosomes; 

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: ";"
Processing 00000000.tx.22: apoptosis; 

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.23: -cell THE HUMAN IDURONATE-2-SULFATASE (IDS) gene contains nine exons spread over 25 kb and is located on the Xq28 chromosome band. 

Phrase: "-cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "THE HUMAN IDURONATE-2-SULFATASE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   923   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   812   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IDS) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415882:IDS gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "nine exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "spread over 25 kb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332261:Spread [Qualitative Concept]
   770   C1947932:Spread [Activity]

Phrase: "and"

Phrase: "is"

Phrase: "located on the Xq28 chromosome band."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008627:chromosome band [Laboratory Procedure,Molecular Biology Research Technique]
   790   C1521913:Chromosome band [Cell Component]
           band
   753   C0008633:Chromosome [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1520200:Xq28 [Cell Component]
Processing 00000000.tx.24: The IDS full-length cDNA encodes a protein of 550 amino acids (12, 41, 42). 

Phrase: "The IDS full-length cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a protein of 550 amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(12,"

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.25: Biosynthesis and processing of IDS have been studied in transfected fibroblasts. 

Phrase: "Biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "processing of IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "studied in transfected fibroblasts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016030:Fibroblasts [Cell]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]
Processing 00000000.tx.26: The enzyme (EC 3.1.6.13 [EC] ) is synthesized as two 76,000- and 90,000-molecular weight precursor forms; 

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(EC 3.1.6.13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0023689:EC 6 [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0030016:EC 1 [Amino Acid, Peptide, or Protein,Enzyme]
   853   C1417734:EC-1 [Gene or Genome]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[EC] )"

Phrase: "is"

Phrase: "synthesized as two 76,000-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205448:Two [Quantitative Concept]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "90,000-molecular weight precursor forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0348078:forms [Qualitative Concept]
   799   C0376315:Forms [Manufactured Object]
   766 E C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.27: subsequent modification of N-linked sugar residues, with the addition of mannose 6-phosphate, targets newly synthesized IDS to lysosomal compartments, where, after proteolytic cleavage, it is converted to mature 55,000- and 45,000-molecular weight polypeptides (13, 25). 

Phrase: "subsequent modification of N-linked sugar residues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "with the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of mannose 6-phosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065688:mannose-6-phosphate [Biologically Active Substance,Carbohydrate]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "newly synthesized IDS to lysosomal compartments,"

Phrase: "where,"

Phrase: "after"

Phrase: "proteolytic cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "it"

Phrase: "is"

Phrase: "converted to mature 55,000-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205286:Mature [Temporal Concept]
   760   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "45,000-molecular weight polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "(13,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.28: Murine Ids cDNA, which encodes 564 amino acid residues, has also been cloned and characterized (36). 

Phrase: "Murine Ids cDNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "564 amino acid residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.29: The coding sequence of the murine gene has 85% identity to the human gene, and the amino acid sequence is 89% identical. 

Phrase: "The coding sequence of the murine gene"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0079941:Coding Sequence [Gene or Genome]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0009219:Coding [Occupational Activity]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]
   714 E C0805701:Code [Intellectual Product]

Phrase: "has"

Phrase: "85% identity to the human gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "the amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "89% identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.30: In addition, molecular defects in the IDS gene, which provoke a defect in the enzymatic activity leading to the accumulation of partially degraded glycosaminoglycans in lysosomes, have been described (18). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "molecular defects in the IDS gene,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0243067:defects [Functional Concept]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "which"

Phrase: "provoke"

Phrase: "a defect in the enzymatic activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]

Phrase: "leading to the accumulation of partially degraded glycosaminoglycans"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   744   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0332152:Leading [Temporal Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1881707:DEGRADED [Phenomenon or Process]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   711 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "in lysosomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.31: This results in the development in humans of Hunter syndrome or mucopolysaccharidosis type II, which is a rare X-linked recessive lysosomal storage disorder (19, 28). 

Phrase: "This results in the development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "of Hunter syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026705:Hunter's Syndrome [Disease or Syndrome]
  1000   C1415882:HUNTER SYNDROME [Gene or Genome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "or"

Phrase: "mucopolysaccharidosis type II,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0026705:Mucopolysaccharidosis Type 2 [Disease or Syndrome]
           Mucopolysaccharidosis II
  1000   C1415882:MUCOPOLYSACCHARIDOSIS TYPE II [Gene or Genome]
   901   C0441730:Type II [Classification]
   827   C0026703:Mucopolysaccharidosis [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a rare X-linked recessive lysosomal storage disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   893   C0678236:Rare disorder [Disease or Syndrome]
   845   C0085078:Lysosomal Storage Disorder [Disease or Syndrome]
   795   C0012634:Disorder [Disease or Syndrome]

Phrase: "(19,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.32: IDS is a lysosomal enzyme involved in the degradation of glycosaminoglycans. 

Phrase: "IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a lysosomal enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0391845:Lysosomal enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "involved in the degradation of glycosaminoglycans."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C1156907:glycosaminoglycan degradation [Molecular Function]
   767   C1512234:Glycosaminoglycan Degradation [Functional Concept]
   753   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1314939:Involved [Functional Concept]
   719 E C3536869:Glycosaminoglycan [Pharmacologic Substance]
Processing 00000000.tx.33: Its activity is based on the removal the 2-sulfate group of the L-iduronate 2-sulfate units of dermatan sulfate proteoglycan 3 and heparan sulfate proteoglycan 2 (HSPG2) (17). 

Phrase: "Its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "based on the removal"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the 2-sulfate group of the L-iduronate 2-sulfate units"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0441846:Group L [Intellectual Product]
   754   C0441865:Group 2 [Intellectual Product]
   738   C0441833:Group [Idea or Concept]
   738   C0687744:group [Population Group]
   738   C1257890:Group [Population Group]
   738   C1552516:Group [Health Care Related Organization]
   738   C1705428:Group [Conceptual Entity]
   738   C1705429:Group [Population Group]

Phrase: "of dermatan sulfate proteoglycan 3"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1825058:DERMATAN SULFATE PROTEOGLYCAN 3 [Gene or Genome]
   923   C0057488:dermatan sulfate proteoglycan [Amino Acid, Peptide, or Protein,Carbohydrate]
   923   C1869122:DERMATAN SULFATE PROTEOGLYCAN [Disease or Syndrome]
   861   C0011602:Dermatan Sulfate [Biologically Active Substance,Carbohydrate]
           Dermatan
   861   C1418890:PROTEOGLYCAN 3 [Gene or Genome]
   812   C0033692:Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "heparan sulfate proteoglycan 2 (HSPG2)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0136134:heparan sulfate proteoglycan 2 [Amino Acid, Peptide, or Protein]
  1000   C1415793:heparan sulfate proteoglycan 2 [Gene or Genome]
   923   C0062503:Heparan Sulfate Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   861   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   861   C1418889:PROTEOGLYCAN 2 [Gene or Genome]
   812   C0033692:Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C2327880:Heparan [Biologically Active Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.34: HSPG2, also known as perlecan, has been identified in islet cells (20) and is thought to be involved in the formation of pancreatic amyloid deposits described in type 2 diabetes (43); 

Phrase: "HSPG2,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0136134:heparan sulfate proteoglycan 2 [Amino Acid, Peptide, or Protein]
  1000   C1415793:heparan sulfate proteoglycan 2 [Gene or Genome]
   923   C0062503:Heparan Sulfate Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   861   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   861   C1418889:PROTEOGLYCAN 2 [Gene or Genome]
   812   C0033692:Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C2327880:Heparan [Biologically Active Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "also"

Phrase: "known as perlecan,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0136134:perlecan [Amino Acid, Peptide, or Protein]
   790   C0205309:Known [Qualitative Concept]
   790   C1415793:PERLECAN [Gene or Genome]
   790   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "been"

Phrase: "identified in islet cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C0805527:Cells identified [Laboratory or Test Result]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the formation of pancreatic amyloid deposits"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C2936349:Amyloid Deposits [Acquired Abnormality]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0220781:formation [Biologic Function]
   744   C0333562:Deposits [Functional Concept]
   744   C0439634:formation [Spatial Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "described in type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1552738:described [Idea or Concept]

Phrase: "(43"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.35: however, overproduction of the perlecan core protein is insufficient to lead to amyloidosis (16). 

Phrase: "however,"

Phrase: "overproduction of the perlecan core protein"

Phrase: "is"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "lead to amyloidosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002726:Amyloidosis [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.36: Glycosaminoglycans, including perlecan, are components of extracellular amyloid deposits formed from islet amyloid polypeptide (IAPP) (7, 40). 

Phrase: "Glycosaminoglycans,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   966 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "perlecan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "components of extracellular amyloid deposits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "formed from islet amyloid polypeptide"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   862   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0205431:Formed [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: ")"

Phrase: "(7,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.37: In addition, perlecan, localized in the basement membrane of capillaries, may contribute to amyloid deposition in Alzheimer's disease, familial amyloidoses, prion diseases (22, 35, 38), and pathogenesis of diabetes complications (6). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "perlecan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "localized in the basement membrane of capillaries,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0004799:Basement membrane [Tissue]
   748   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   748   C0025255:Membrane [Tissue]
   748   C0392752:Localized [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   748   C1706182:Membrane [Manufactured Object]
   748   C1979853:Basement [Cell Component]
   714 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "contribute to amyloid deposition"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   833   C1705760:Amyloid Deposition [Finding]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0333562:Deposition [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1880177:Contribute [Activity]

Phrase: "in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "familial amyloidoses,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0740340:Familial Amyloidoses [Disease or Syndrome]
   861   C0002726:Amyloidoses [Disease or Syndrome]
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "prion diseases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(22,"

Phrase: "35,"

Phrase: "38"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pathogenesis of diabetes complications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.38: Furthermore, recent studies have demonstrated that heparin and perlecan can bind the human NH2-terminal pro-IAPP molecule, acting as a potent enhancer of IAPP fibril formation in vitro (3, 30). 

Phrase: "Furthermore,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the human NH2-terminal pro-IAPP molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0567416:Molecule [Substance]
   727 E C1521991:Molecular [Qualitative Concept]

Phrase: "acting as a potent enhancer of IAPP fibril formation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C2247818:IAPP formation [Molecular Function]
   742   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0220781:formation [Biologic Function]
   742   C0225328:Fibril [Cell Component]
   742   C0439634:formation [Spatial Concept]
   742   C1415831:IAPP [Gene or Genome]
   742   C1522492:Formation [Functional Concept]
   742   C1948066:Fibril [Physical Object]
   708   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.39: Preliminary studies using differential display procedures have found that the IDS gene is preferentially expressed in pancreatic islets relative to exocrine tissue (11). 

Phrase: "Preliminary studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "differential display procedures"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]
   734   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the IDS gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415882:IDS gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "preferentially"

Phrase: "expressed in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "relative to exocrine tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.40: However, some information related to the identification of IDS in islets cells has been published. 

Phrase: "However,"

Phrase: "some information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "related to the identification of IDS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "in islets cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   983   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "published."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]
Processing 00000000.tx.41: In this sense, the present work is focused on examining the expression and the main determination of metabolic regulation of the Ids gene in mouse pancreatic islets.  

Phrase: "In this sense,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "the present work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "focused on examining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205234:Focused [Spatial Concept]
   790   C0332128:examining [Finding]
   790   C1285542:focused [Functional Concept]
   790   C2004054:Examining [Activity]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the main determination of metabolic regulation of the Ids gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1148554:determination [Laboratory Procedure]

Phrase: "in mouse pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1522528:Mouse Islets [Tissue]
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.42: MATERIALS AND METHODS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Mouse Pancreatic Islet Isolation and Culture Mouse pancreatic islets were isolated from 2-mo-old CD-1 male mice by a modification of the procedure originally described by Lacy and Kostianovsky (23). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mouse Pancreatic Islet Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0204727:Isolation [Therapeutic or Preventive Procedure]
   812   C0205409:Isolation [Functional Concept]
   812   C0220862:isolation [Laboratory Procedure]
   741 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Culture Mouse pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1522528:Mouse Islets [Tissue]
   861   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from 2-mo-old CD-1 male mice"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   742   C0024554:Male [Finding]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0086582:male [Population Group]
   742   C0205409:Isolated [Functional Concept]
   742   C0580836:Old [Temporal Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1706180:Male [Qualitative Concept]
   742   C1706428:Male [Qualitative Concept]
   742   C1706429:Male [Organism Attribute]
   742   C3538743:MO [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of the procedure originally"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "described by Lacy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1552738:described [Idea or Concept]
   718   C0280109:LACE [Therapeutic or Preventive Procedure]
   718   C0453991:Laces [Manufactured Object]

Phrase: "and"

Phrase: "Kostianovsky"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.43: Briefly, the pancreas was cannulated and digested with collagenase (Roche Diagnostics, Mannheim, Germany), and islets were purified from the exocrine tissue through discontinuous Histopaque density gradients. 

Phrase: "Briefly,"

Phrase: "the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "cannulated"

Phrase: "and"

Phrase: "digested with collagenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0868946:digested [Physiologic Function]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "islets"

Phrase: "were"

Phrase: "purified from the exocrine tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1998793:Purified [Functional Concept]

Phrase: "through discontinuous Histopaque density gradients."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0178587:density [Quantitative Concept]
   812   C0812409:gradients [Quantitative Concept]
   779 E C0439182:% gradient [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.44: Groups of 100 islets were hand picked under a stereomicroscope, transferred to petri dishes, and precultured for 18 h in RPMI 1640 medium (GIBCO-BRL Life Technologies, Paisley, UK) supplemented as described previously (14). 

Phrase: "Groups of 100 islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "hand picked under a stereomicroscope,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0018563:Hand [Body Part, Organ, or Organ Component]
   760   C1281583:Hand [Body Part, Organ, or Organ Component]
   760   C1552914:hand [Quantitative Concept]
   760   C1707391:Picked [Activity]
   726 E C1826583:PICK [Gene or Genome]
   704 E C0024763:Manual [Intellectual Product,Manufactured Object]
   704 E C0175674:Manual [Functional Concept]

Phrase: "transferred to petri dishes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C1322960:Petri dish [Medical Device]
   770   C0348011:transferred [Functional Concept]
   737   C0020498:DISH [Disease or Syndrome]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "precultured for 18 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in RPMI 1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(GIBCO-BRL Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0039421:technologies [Occupation or Discipline]

Phrase: "Paisley,"

Phrase: "UK"

Phrase: ")"

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.45: Then the islets were transferred to 10 ml of new RPMI 1640 medium supplemented with a range of test agents for a further 24 h in the same conditions. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the islets"

Phrase: "were"

Phrase: "transferred to 10 ml of new RPMI 1640 medium"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0009458:Medium [Intellectual Product]
   742   C0205314:New [Temporal Concept]
   742   C0348011:transferred [Functional Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]
   708 E C0040671:Transfer [Mental Process]
   708 E C1705822:Transfer [Activity]

Phrase: "supplemented with a range of test agents"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]
   714   C0242295:Supplement [Food]
   714   C0450442:Agent [Chemical Viewed Functionally]
   714   C1254351:Agent [Pharmacologic Substance]
   714   C1521826:Agent [Intellectual Product]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "for a further 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "in the same conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.46: Gene Expression Analyses Total RNA from mouse pancreatic islets was extracted using QuickPrep Total RNA Extraction Kit (Amersham Pharmacia Biotech) and from the exocrine tissue by the guanidine isothiocyanate method (4). 

Phrase: "Gene Expression Analyses Total RNA from mouse pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0040649:RNA Expression [Genetic Function]
   745   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "QuickPrep Total RNA Extraction Kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and from the exocrine tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040300:Tissue [Tissue]
   760   C1515981:And [Idea or Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "by the guanidine isothiocyanate method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C0061946:guanidine isothiocyanate [Organic Chemical]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.47: After digestion with DNase (GIBCO-BRL) for 15 min at room temperature, cDNAs were synthesized using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI) following the manufacturer's instructions. 

Phrase: "After digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with DNase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature, cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C2348236:ROOM TEMPERATURE [Qualitative Concept]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Moloney murine leukemia virus reverse transcriptase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1555029:Reverse [Idea or Concept]
   799   C2257077:transcriptase [Genetic Function]
   734   C0026398:Moloney murine leukemia virus [Virus]
           Moloney Leukemia Virus

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Madison,"

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.48: These cDNAs were used as the PCR template for reactions set up in the presence of specific primers (Table 1), dNTPs, and Taq DNA polymerase (Promega). 

Phrase: "These cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used as the PCR template"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0728990:TEMPLATE [Medical Device]
   760   C1273517:used [Finding]
   760   C1514575:Template [Conceptual Entity]
   760   C1705542:Template [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for reactions set up"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "dNTPs,"

Phrase: "and"

Phrase: "Taq DNA polymerase (Promega)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
  1000   C2257065:Taq DNA polymerase [Genetic Function]
   901   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.49: Twenty milliliters of the PCR products were examined by electrophoresis on 2% agarose gel after electrophoresis. 

Phrase: "Twenty milliliters of the PCR products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439242:milliliter [Quantitative Concept]

Phrase: "were"

Phrase: "examined by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0332128:Examined [Finding]

Phrase: "on 2% agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "after electrophoresis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]
Processing 00000000.tx.50: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.51: Primer and probe sequences used for RT-PCR and quantitative real-time RT-PCR  Quantitative real-time RT-PCR of IDS, Ids, insulin, Iapp, perlecan, and ribosomal protein S18 (Rps18) was performed. 

Phrase: "Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "probe sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "used for RT-PCR"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "quantitative real-time RT-PCR  Quantitative real-time RT-PCR"

Phrase: "of IDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "Ids,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Iapp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "perlecan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ribosomal protein S18 (Rps18)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0073319:ribosomal protein S18 [Amino Acid, Peptide, or Protein]
  1000   C1419717:RIBOSOMAL PROTEIN S18 [Gene or Genome]
           S18
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.52: The primers and probes (Table 1) were selected with Primer Express software (Applied Biosystems). 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "selected with Primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1707391:Select [Activity]

Phrase: "Express"

Phrase: "software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.53: Amplifications were carried out using Prism 7900HT Sequence Detection System (Applied Biosystems) containing 5 ng of cDNA template per sample and the endogenous detection probe TaqMan 18S rRNA (Applied Biosystems) to generate multiplex PCR. 

Phrase: "Amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1517480:Amplification [Molecular Biology Research Technique]
   966   C1521871:Amplification [Phenomenon or Process]
   966   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Prism 7900HT Sequence Detection System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 ng of cDNA template"

Phrase: "per sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "the endogenous detection probe TaqMan 18S rRNA (Applied Biosystems"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "multiplex PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3179032:Multiplex PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.54: Serial dilutions of partial cDNA sequence of gene targets were used to acquire the standard curve in each experiment. 

Phrase: "Serial dilutions of partial cDNA sequence of gene targets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0031082:serial [Intellectual Product,Manufactured Object]
   742   C0079240:dilutions [Laboratory Procedure]
   708 E C1948037:Dilution [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the standard curve in each experiment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.55: In every assay, runs were independently repeated twice, and a negative control was included. 

Phrase: "In every assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "runs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0600140:Runs [Finding]
   966 E C0035953:run [Daily or Recreational Activity]
   966 E C1704688:Run [Functional Concept]
   966 E C2346414:Run [Finding]

Phrase: "were"

Phrase: "independently"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "twice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "a negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.56: Data analysis was performed using SDS software (version 2.1, Applied Biosystems). 

Phrase: "Data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SDS software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 2.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.57: Then the Rps18 was used as a reference against which the expression level of the transcript genes of interest was normalized. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the Rps18"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0073319:ribosomal protein S18 [Amino Acid, Peptide, or Protein]
  1000   C1419717:RIBOSOMAL PROTEIN S18 [Gene or Genome]
           S18
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "was"

Phrase: "used as a reference"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "against which"

Phrase: "the expression level of the transcript genes of interest"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   784   C0424090:Level of interest [Mental Process]
   764   C3244092:expression level [Idea or Concept]
   745   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "normalized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]
Processing 00000000.tx.58: Subcellular Location of IDS Plasmid construction. 

Phrase: "Subcellular Location of IDS Plasmid construction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]
Processing 00000000.tx.59: Human IDS cDNA (GenBank accession no. NM 000202) was generated by PCR using the PfuI enzyme (Stratagene, Amsterdam, The Netherlands), and the primers IDS/NheI (5'-ATCTAGCTAGCGAAATGCCGCCACC-3') and IDS/XhoI (5'-CCGCTCGAGACAACTGGAAAAGATCTCCAC-3') were designed to create NheI and XhoI sites at 5' and 3' tails, respectively. 

Phrase: "Human IDS cDNA (GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1510755:Accession [Intellectual Product]
   804   C1706078:Accession [Activity]

Phrase: "no. NM 000202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "was"

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PfuI enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(Stratagene,"

Phrase: "Amsterdam,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the primers IDS/NheI"

Phrase: "(5'-ATCTAGCTAGCGAAATGCCGCCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "IDS/XhoI"

Phrase: "(5'-CCGCTCGAGACAACTGGAAAAGATCTCCAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "NheI"

Phrase: "and"

Phrase: "XhoI sites at 5'"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "3' tails,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039259:Tails [Body Part, Organ, or Organ Component]

Phrase: "respectively."
Processing 00000000.tx.60: The NheI-XhoI fragment of the resulting PCR product was inserted into the NheI-XhoI sites of pEGFP-N1 vector (Clontech, Palo Alto, CA). 

Phrase: "The NheI-XhoI fragment of the resulting PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "inserted into the NheI-XhoI sites of pEGFP-N1 vector"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   743   C2945843:Site of [Qualitative Concept]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205145:Sites [Spatial Concept]
   739   C0441587:Inserted [Health Care Activity]
   739   C0441962:N1 [Finding]
   739   C0442335:Vector [Spatial Concept]
   739   C1705099:Vector [Idea or Concept]
   724   C1705686:Insert Site [Nucleotide Sequence]
   706 E C1515974:Site [Body Location or Region]
   706 E C1743766:Insert [Medical Device]
   706 E C1883719:Insert [Functional Concept]
   706 E C2825164:Site [Spatial Concept]

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.61: Cell culture and transfection. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.62: MIN6 (a cell line derived from an insulinoma of transgenic mice) and -TC1 cells (a cell line derived from a pancreatic adenoma created in transgenic mice) were grown on tissue culture test plates in Dulbecco's modified Eagle's medium (Bio Whittaker Europe, Verviers, Belgium) supplemented with 15% fetal calf serum (GIBCO-BRL), penicillin (100 U/ml), streptomycin (100 g/ml), and 2 l of 5 M -mercaptoethanol (GIBCO-BRL). 

Phrase: "MIN6"

Phrase: "(a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "derived from an insulinoma of transgenic mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0025936:Mice, Transgenic [Mammal]
   757   C1522248:Mouse Insulinoma [Neoplastic Process]
   748   C0003069:Transgenic [Animal]
   748   C0021670:insulinoma [Neoplastic Process]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "and -"

Phrase: "TC1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0949431:TC1 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "derived from a pancreatic adenoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1142432:Pancreatic adenoma [Neoplastic Process]
   760   C0001430:Adenoma [Neoplastic Process]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "created in transgenic mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1706214:Created [Activity]
   737 E C3244320:create [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "grown on tissue culture test plates"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0040284:Tissue culture [Laboratory Procedure]
   783   C0180454:culture plates [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0040300:Tissue [Tissue]
   753   C0220814:culture [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1139930:plates [Medical Device]
   753   C1547928:Tissue [Intellectual Product]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C0005971:Plate [Medical Device]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "(Bio Whittaker Europe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015176:Europe [Geographic Area]

Phrase: "Verviers,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "supplemented with 15% fetal calf serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030842:Penicillin [Antibiotic,Organic Chemical]
  1000   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "(100 U/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(100 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "2 l of 5"

Phrase: "M -"

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.63: Cells were transfected with the IDS-pEGFP-N1 and pEGFP vector by use of the Lipofectamine Plus kit (GIBCO-BRL) according to the manufacturer's protocol. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the IDS-pEGFP-N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "pEGFP vector by use of the Lipofectamine Plus kit (GIBCO-BRL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0442335:Vector [Spatial Concept]
   738   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.64: Immunofluorescence. 

Phrase: "Immunofluorescence."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.65: Colocalization of IDS with lysosomal enzymes was performed using the lysosome-associated membrane proteins (LAMP-2) polyclonal antibody (Santa Cruz Biotechnology) and an anti-goat IgG-tetramethylrhodamine isothiocyanate conjugate (Sigma, St. Louis, MO) as a second antibody. 

Phrase: "Colocalization of IDS"

Phrase: "with lysosomal enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0391845:Lysosomal enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lysosome-associated membrane proteins (LAMP-2) polyclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C2599273:Lysosome Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   822   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1566771:Lysosome-Associated Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "and"

Phrase: "an anti-goat IgG-tetramethylrhodamine isothiocyanate conjugate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0301869:Conjugate [Immunologic Factor]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO) as a second antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3538743:MO [Idea or Concept]
Processing 00000000.tx.66: Fluorescence images were analyzed with a Leica TCS NT confocal scanning laser microscope. 

Phrase: "Fluorescence images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "analyzed with a Leica TCS NT confocal scanning laser microscope."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   757   C1626420:Confocal microscope [Medical Device]
   739   C0023089:Laser [Manufactured Object]
   739   C0034606:Scanning [Diagnostic Procedure]
   739   C0181839:Microscope [Medical Device]
   739   C0242387:TCS [Congenital Abnormality]
   739   C0332126:NT [Qualitative Concept]
   739   C0441633:Scanning [Diagnostic Procedure]
   739   C0458142:Laser [Phenomenon or Process]
   739   C0936012:Analyzed [Research Activity]
   739   C1023865:Laser [Plant]
   739   C1449832:NT [Diagnostic Procedure]
   739   C1706315:Laser [Medical Device]
   739   C1706379:Microscope [Medical Device]
   706 E C2826292:SCAN [Finding]
Processing 00000000.tx.67: Lentiviral Vector Constructions and Infection To determine the effects of overexpression of the IDS gene, cells were infected with the gene in lentiviral vectors. 

Phrase: "Lentiviral Vector Constructions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Infection To"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of overexpression of the IDS gene,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with the gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0439663:Infected [Functional Concept]

Phrase: "in lentiviral vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.68: This transduction system permits the efficient integration of genes into the genome of nondividing cells (10). 

Phrase: "This transduction system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the efficient integration of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158478:Integration [Genetic Function]
   760   C1705422:Integration [Machine Activity]

Phrase: "into the genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "of nondividing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512899:Non-dividing Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.69: The strategy of plasmid constructs described above was followed to clone sense and antisense IDS cDNA into the MluI-XhoI sites of pHR-CMV vector (kindly provided by B. Thorens, University of Lausanne). 

Phrase: "The strategy of plasmid constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679199:strategy [Mental Process]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "was"

Phrase: "followed to clone sense"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0009013:Clone [Cell]
   770   C0036658:sense [Organ or Tissue Function]
   770   C0332283:followed [Temporal Concept]
   770   C1522642:Clone [Tissue]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "antisense IDS cDNA into the MluI-XhoI sites of pHR-CMV vector"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(kindly"

Phrase: "provided by B. Thorens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "University of Lausanne"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.70: The oligonucleotides were as follows: 5'-AATCGACGCGTGAAATGCCGCCACC-3' (sense) and 5'-TCGACGCGTGCATCAACAACTGG-3' (antisense) for MluI/IDS and 5'-ACCGCTCGAGTCAACAACTGG-3' (sense) and 5'-ACCGCTCGAGGAAATGCCGCCACC-3' (antisense) for XhoI/IDS. 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "5'-AATCGACGCGTGAAATGCCGCCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-TCGACGCGTGCATCAACAACTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "for MluI/IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "5'-ACCGCTCGAGTCAACAACTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-ACCGCTCGAGGAAATGCCGCCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "for XhoI/IDS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]
Processing 00000000.tx.71: The envelope plasmid pMDG and the packaging plasmid pCMVDR8.7 were described previously (10) (supplied by B. Thorens). 

Phrase: "The envelope plasmid pMDG"

Phrase: "and"

Phrase: "the packaging plasmid pCMVDR8.7"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013194:Packaging [Medical Device]
   812   C0030176:Packaging [Human-caused Phenomenon or Process]
   812   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C2828395:Packaging [Activity]
   779 E C2700580:Package [Manufactured Object]

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")"

Phrase: "("

Phrase: "supplied by B. Thorens"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C1999230:Supplied [Activity]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]

Phrase: ")."
Processing 00000000.tx.72: Virus stocks were prepared as previously described (26, 27) by transient cotransfection of three plasmids into 293T cells. 

Phrase: "Virus stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "by transient cotransfection"

Phrase: "of three plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "into 293T cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.73: The medium was collected after 48 h and filtered through a 0.45-mm pore-size filter and concentrated by ultracentrifugation. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected after 48 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "filtered through a 0.45-mm pore-size filter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0456389:size [Spatial Concept]
   742   C1325742:Pore [Cell Component]
   708   C0180860:Filter [Manufactured Object]
   708   C0581406:Filter [Medical Device]
   708   C1522664:Filter [Intellectual Product]
   708   C1704449:Filter [Conceptual Entity]
   708   C1704684:Filter [Medical Device]
   708   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "concentrated by ultracentrifugation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0041609:Ultracentrifugation [Laboratory Procedure]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]
Processing 00000000.tx.74: The viral titer was calculated by quantification of the p24 content by ELISA (Innogenetics). 

Phrase: "The viral titer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475208:Titer [Quantitative Concept]

Phrase: "was"

Phrase: "calculated by quantification of the p24 content"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0054970:p24 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0423896:Content [Mental Process]
   748   C0444686:Calculated [Functional Concept]
   748   C0456205:Content [Conceptual Entity]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1709793:Quantification [Quantitative Concept]
   748   C1846989:p24 [Gene or Genome]
   748   C3539699:P24 [Gene or Genome]

Phrase: "by ELISA (Innogenetics"

Phrase: ")."
Processing 00000000.tx.75: The islets were infected with lentiviral particles (20 IU/-cell) for 4 h and then cultured in the corresponding medium for 48 h. 

Phrase: "The islets"

Phrase: "were"

Phrase: "infected with lentiviral particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439663:Infected [Functional Concept]
   770   C0597177:particles [Chemical Viewed Structurally]

Phrase: "(20 IU/-cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cultured in the corresponding medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.76: To assess the efficiencies of the lentiviral vector infection of mouse islet, expression of IDS was determined by quantitative real-time RT-PCR. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the efficiencies of the lentiviral vector infection of mouse islet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0013682:efficiencies [Quantitative Concept]

Phrase: "expression of IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined by quantitative real-time RT-PCR."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.77: Insulin Secretion and Content After lentivirus infections, groups of eight mouse islets were placed in 1 ml of bicarbonate-buffered solution with 5 mg/ml BSA in the presence of 5.5 and 16.7 mM glucose and incubated for 90 min at 37C in a shaking water bath. 

Phrase: "Insulin Secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Content After lentivirus infections,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "groups of eight mouse islets"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1522528:Mouse Islets [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205454:Eight [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "placed in 1 ml of bicarbonate-buffered solution"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0037633:Solution [Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C0973231:Bicarbonate [Inorganic Chemical]
   744   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]

Phrase: "with 5 mg/ml BSA"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450380:5/5 [Quantitative Concept]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "16.7 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated for 90 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in a shaking water bath."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0150141:Bath [Therapeutic or Preventive Procedure]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.78: The supernatants were then stored at 20C until radioimmunoassay for insulin (CIS Biointernational, Gif-Sur-Yvette, France; detection limit = 30 pM, intra- and interassay coefficients of variation = 6 and 8%, respectively). 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stored at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until radioimmunoassay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(CIS Biointernational,"

Phrase: "Gif-Sur-Yvette,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "; detection limit"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2718050:Detection Limit [Quantitative Concept]
   861   C0439801:limit [Functional Concept]
   861   C1549649:Limit [Idea or Concept]
   861   C2349209:Limit [Conceptual Entity]
   789 E C3542948:Limited [Intellectual Product]

Phrase: "= 30 pM, intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "interassay coefficients of variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   890   C0681921:Coefficient of Variation [Quantitative Concept]
   812   C0205419:Variation [Qualitative Concept]
   779   C1707429:*Coefficient [Quantitative Concept]

Phrase: "= 6"

Phrase: "and"

Phrase: "8%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.79: For the determination of insulin content, the same islets were disintegrated by sonication at 4C in 0.5 ml of acid-ethanol solution (75% ethanol and 1.5% 10 mM HCl). 

Phrase: "For the determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "of insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the same islets"

Phrase: "were"

Phrase: "disintegrated by sonication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0037680:Sonication [Research Activity]
   756   C1880357:DISINTEGRATE [Phenomenon or Process]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 0.5 ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439526:/mL [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "of acid-ethanol solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(75% ethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "and"

Phrase: "1.5% 10 mM HCl"

Phrase: ")."
Processing 00000000.tx.80: Analysis of Islet Cell Viability Isolation of single mouse islet cells. 

Phrase: "Analysis of Islet Cell Viability Isolation of single mouse islet cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597452:Single-Cell Analysis [Laboratory Procedure]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
Processing 00000000.tx.81: After lentiviral vector infection, single mouse islet cells were obtained by digesting 50 mouse islets in 2 ml of PBS containing 0.125 mg/ml trypsin and 0.05 mg/ml EDTA (GIBCO-BRL) at 37C. 

Phrase: "After lentiviral vector infection,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0009450:Infection, NOS [Disease or Syndrome]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "single mouse islet cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   906   C1522528:Mouse Islet Cell [Tissue]
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained by digesting 50 mouse islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1522528:Mouse Islets [Tissue]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0868946:digesting [Physiologic Function]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "in 2 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.125 mg/ml trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.05 mg/ml EDTA (GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "at 37C."
Processing 00000000.tx.82: The cell suspension was cycled for 5 min at 37C and for an additional 5 min on ice to allow islets to sediment. 

Phrase: "The cell suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "was"

Phrase: "cycled for 5 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2348028:Cycle/min [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]
   737   C1511572:Cycle [Temporal Concept]

Phrase: "at 37C"

Phrase: "and for an additional 5 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0702093:/min [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1524062:Additional [Functional Concept]

Phrase: "on ice to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020746:Ice [Inorganic Chemical]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "islets to sediment."
Processing 00000000.tx.83: Then the supernatant containing the single cells was removed and placed in 1 ml of fetal calf serum (GIBCO-BRL). 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "placed in 1 ml of fetal calf serum"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0015965:Fetal [Embryonic Structure]
   744   C0229671:Serum [Body Substance]
   744   C0230445:Calf [Body Location or Region]
   744   C0439526:/mL [Quantitative Concept]
   744   C0521457:Fetal [Functional Concept]
   744   C1305418:Calf [Body Part, Organ, or Organ Component]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]

Phrase: "(GIBCO-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.84: To obtain additional single islet cells, the digestion process was repeated a maximum of four times. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "additional single islet cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the digestion process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "a maximum of four times."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]
Processing 00000000.tx.85: Fluorescence-activated cell sorting. 

Phrase: "Fluorescence-activated cell sorting."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   861   C0007616:Cell Sorting [Laboratory Procedure]
   812   C0007634:Cell [Cell]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0237886:Sorting [Mental Process]
   812   C0700314:sorting [Cell Function]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1879547:Activated [Activity]
   812   C1947906:Sorting [Activity]
   812   C1948049:Cell [Spatial Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.86: Isolated islet cells were pelleted, washed, and resuspended in 400 l of binding buffer [in mM: 100 HEPES (pH 7.4), 1.5 NaCl, 50 KCl, 10 MgCl2, and 18 CaCl2]. 

Phrase: "Isolated islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "resuspended in 400 l of binding buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "["

Phrase: "in mM"

Phrase: ":"

Phrase: "100 HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "1.5 NaCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "50 KCl,"

Phrase: "10 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "18 CaCl2"

Phrase: "]."
Processing 00000000.tx.87: For each experimental condition, 200 l of cells were unlabeled and used to define the threshold of detection in fluorescence-activated cell sorting (FACS) analysis. 

Phrase: "For each experimental condition,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "200 l of cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   819   C0347983:cells/L [Quantitative Concept]
   802 E C0022827:cell l [Cell]

Phrase: "were"

Phrase: "unlabeled"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the threshold of detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "in fluorescence-activated cell sorting (FACS) analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
Processing 00000000.tx.88: The other 200 l of cell solution were double stained with annexin V-phycoerythrin (PE) and 7-amino-actinomycin D (7-AAD) by using Annexin V-PE Apoptosis Detection Kit I (Becton Dickinson, San Jose, CA) following the manufacturer's instructions. 

Phrase: "The"

Phrase: "other 200 l of cell solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0022827:cell l [Cell]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained with annexin V-phycoerythrin (PE)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332095:ANNEXIN V [Gene or Genome]
   760   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "7-amino-actinomycin D (7-AAD) by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   926   C0049832:7-amino-actinomycin D [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   806   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Annexin V-PE Apoptosis Detection Kit I (Becton Dickinson,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   807   C0331782:Becton Dickinson [Health Care Related Organization]
   700   C0103403:Annexin I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   700   C1412417:ANNEXIN I [Gene or Genome]

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.89: Thereafter, cells were analyzed on a FACS Calibur (Becton Dickinson) with Cell Quest software (Becton Dickinson). 

Phrase: "Thereafter,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed on a FACS Calibur"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   770   C0007616:Cell Sorting [Laboratory Procedure]
   744   C0007634:Cell [Cell]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0237886:Sorting [Mental Process]
   744   C0700314:sorting [Cell Function]
   744   C0936012:Analyzed [Research Activity]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1879547:Activated [Activity]
   744   C1947906:Sorting [Activity]
   744   C1948049:Cell [Spatial Concept]
   711 E C1515877:Activate [Functional Concept]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")"

Phrase: "with Cell Quest software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.90: FACS gating based on forward and side scatter out of 100,000 cells was included for analysis. 

Phrase: "FACS gating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]

Phrase: "based on forward"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0439780:Forward [Spatial Concept]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "side scatter out of 100,000 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439742:scatter [Spatial Concept]
   748   C0441987:Side [Spatial Concept]

Phrase: "was"

Phrase: "included for analysis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0332257:included [Functional Concept]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   790   C3538986:INCLUDED [Gene or Genome]
   756 E C1552866:include [Idea or Concept]
   756 E C2700399:Include [Activity]
Processing 00000000.tx.91: Every run included positive and negative control samples for cell cytotoxicity. 

Phrase: "Every run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative control samples for cell cytotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.92: Negative cells for annexin V and 7-AAD were considered viable cells, early apoptotic cells were annexin V positive, and apopototic or necrotic cells were negative for annexin V and 7-AAD. 

Phrase: "Negative cells for annexin V"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "7-AAD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049832:7-amino-actinomycin D [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "viable cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1441322:Viable cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "early apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "annexin V positive,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]

Phrase: "and"

Phrase: "apopototic"

Phrase: "or"

Phrase: "necrotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "negative for annexin V"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "7-AAD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049832:7-amino-actinomycin D [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.93: Electron Microscopy Lentiviral-infected islets were briefly rinsed with phosphate buffer (PB) and fixed with fresh 4% paraformaldehyde-1% gluteraldehyde in 0.1 M PB, pH 7.4, for 1 h at room temperature. 

Phrase: "Electron Microscopy Lentiviral-infected islets"

Phrase: "were"

Phrase: "briefly"

Phrase: "rinsed with phosphate buffer (PB)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   770   C0031701:phosphate [Organophosphorus Compound]
   770   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "fixed with fresh 4% paraformaldehyde-1% gluteraldehyde"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   748   C0231441:Fixed [Finding]
   748   C0443218:Fixed [Qualitative Concept]
   748   C0443224:Fresh [Qualitative Concept]
   748   C2827483:Fixed [Body Substance]
   748   C2827486:Fresh [Body Substance]

Phrase: "in 0.1 M PB,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.94: Islets were postfixed with OsO4 in 0.1 M PB for 1 h at 4C. 

Phrase: "Islets"

Phrase: "were"

Phrase: "postfixed with OsO4"

Phrase: "in 0.1 M PB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.95: Islets for immunolabeling were dehydrated through ascending series of ethanol to 80% and infiltrated with 1:1 80% ethanol-LR White hydrophilic acrylic resin (London Resin, Berkshire, UK); 

Phrase: "Islets for immunolabeling"

Phrase: "were"

Phrase: "dehydrated through ascending series of ethanol"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0011175:Dehydrated [Disease or Syndrome]
   753   C0205385:Ascending [Qualitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C1547175:Ascending [Functional Concept]
   753   C1962987:Ascending [Functional Concept]
   753   C2348044:Series [Intellectual Product]
   719 E C0308355:ASCEND [Organic Chemical,Pharmacologic Substance]

Phrase: "to 80%"

Phrase: "and"

Phrase: "infiltrated with 1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0332448:infiltrated [Pathologic Function]
   756 E C1546677:Infiltrate [Intellectual Product]
   756 E C1549537:Infiltrate [Functional Concept]

Phrase: ":"

Phrase: "1 80% ethanol-LR White hydrophilic acrylic resin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   855   C0065208:LR-white resin [Biomedical or Dental Material,Chemical Viewed Structurally]
   812   C0001222:acrylic resin [Biomedical or Dental Material]
   793   C0035191:Resin [Biomedical or Dental Material]
   793   C0440181:Acrylic [Biomedical or Dental Material,Organic Chemical]

Phrase: "(London Resin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035191:Resin [Biomedical or Dental Material]

Phrase: "Berkshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454841:Berkshire [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.96: then undiluted LR White was changed twice at room temperature. 

Phrase: "then undiluted LR White"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0065208:LR white [Biomedical or Dental Material,Chemical Viewed Structurally]
   812   C0007457:White [Population Group]
   812   C0043157:White [Population Group]
   812   C0220938:White [Qualitative Concept]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "twice at room temperature."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.97: The infiltration was continued with fresh LR White overnight at 4C, and, after a final change to fresh resin, embedding was completed by polymerization under vacuum at 55C for 48 h. 

Phrase: "The infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332448:Infiltration [Pathologic Function]
  1000   C0702249:Infiltration [Therapeutic or Preventive Procedure]
  1000   C1523986:Infiltration [Functional Concept]

Phrase: "was"

Phrase: "continued with fresh LR White"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0065208:LR white [Biomedical or Dental Material,Chemical Viewed Structurally]
   760   C0007457:White [Population Group]
   760   C0023617:LR [Geographic Area]
   760   C0043157:White [Population Group]
   760   C0220938:White [Qualitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C0549178:Continued [Idea or Concept]
   760   C2827486:Fresh [Body Substance]
   760   C2986899:LR [Idea or Concept]

Phrase: "overnight at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: ","

Phrase: "after"

Phrase: "a final change to fresh resin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "embedding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707903:Embedding [Laboratory Procedure]

Phrase: "was"

Phrase: "completed by polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205197:COMPLETED [Qualitative Concept]
   790   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "under vacuum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "at 55C"

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.98: After separation of the Thermonox coverslip from the embedded cells, 80- to 100-nm cross sections were cut and mounted on a 150-mesh nickel grid supported with carbon-coated parlodion. 

Phrase: "After separation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036679:Separation [Pathologic Function]
  1000   C0237868:Separation [Social Behavior]
  1000   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "of the Thermonox coverslip"

Phrase: "from the embedded cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "80-"

Phrase: "to 100-nm cross sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0552389:cross sections [Spatial Concept]
   812   C2828360:Cross [Conceptual Entity]
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "mounted on a 150-mesh nickel grid"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0181805:Mesh [Medical Device]
   748   C0449878:mounted [Finding]
   748   C1135584:MeSH [Intellectual Product]
   748   C1415284:GRID [Gene or Genome]
   748   C1552983:Mesh [Quantitative Concept]
   748   C2348274:Nickel [Element, Ion, or Isotope]
   748   C2348395:Grid [Medical Device]
   748   C2825313:Grid [Manufactured Object]
   714 E C0181909:Mount [Medical Device]

Phrase: "supported with carbon-coated parlodion."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007009:Carbon [Element, Ion, or Isotope]
   760   C1521721:Supported [Conceptual Entity]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0183683:Support [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.99: Immunolocalization of IAPP in the islets was performed by treatment of the sections with a polyclonal antibody against IAPP (kindly provided by A. Clark, University of Oxford). 

Phrase: "Immunolocalization of IAPP"

Phrase: "in the islets"

Phrase: "was"

Phrase: "performed by treatment of the sections"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C1550369:Performed By [Qualitative Concept]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0884358:Performed [Functional Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with a polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: "(kindly"

Phrase: "provided by A. Clark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: "University of Oxford"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.100: Antisera binding sites were identified with protein A-conjugated gold particles (15 nm; BB International). 

Phrase: "Antisera binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0005456:Binding Sites [Receptor]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "identified with protein A-conjugated gold particles"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C0522529:Conjugated [Spatial Concept]
   748   C0597177:particles [Chemical Viewed Structurally]
   748   C1304897:Gold [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "(15 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "; BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004739:BB [Geographic Area]
  1000   C0332297:BB [Spatial Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.101: The sections were stained for tissue contrast with uranyl acetate and lead citrate. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained for tissue contrast"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   802   C0282157:Tissue stain [Indicator, Reagent, or Diagnostic Aid]
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C1979874:Contrast [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with uranyl acetate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "lead citrate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008857:Citrate [Organic Chemical]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.102: They were viewed in an electron microscope (model EM 15007, JEOL). 

Phrase: "They"

Phrase: "were"

Phrase: "viewed in an electron microscope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0181845:Electron Microscope [Medical Device]
   760   C0013852:Electron [Quantitative Concept]
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   760   C3463986:Electron [Bird]
   726   C0449911:View [Spatial Concept]

Phrase: "(model EM 15007,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "JEOL"

Phrase: ")."
Processing 00000000.tx.103: Data Presentation and Statistical Analysis Values are means  SE. 

Phrase: "Data Presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449450:Presentation [Idea or Concept]

Phrase: "and"

Phrase: "Statistical Analysis Values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.104: Results are reported relative to expression in the presence of 3 mM glucose or in noninfected islets, which are taken as 100%. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "relative to expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 3 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or in noninfected islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521118:Non-infected [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "taken as 100%."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.105: Data were assessed by use of the nonparametric Wilcoxon's test or the one-sample Student's t-test. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "assessed by use of the nonparametric Wilcoxon's test"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0871608:Wilcoxon Test [Intellectual Product]
   770   C1524063:Use of [Functional Concept]
   767   C1709255:Non-Parametric Test [Intellectual Product]
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0457083:Use [Functional Concept]
   744   C1516048:Assessed [Activity]
   744   C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "the one-sample Student's t-test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   924   C1709321:One Sample t-Test [Intellectual Product]
   804   C0022885:Test [Laboratory Procedure]
   804   C0038492:student [Professional or Occupational Group]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C1551041:student [Idea or Concept]
   804   C1552573:student [Intellectual Product]
Processing 00000000.tx.106: Differences were considered significant when P < 0.05.  

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.107: RESULTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Expression of IDS We examined the gene expression of Ids in islets and exocrine mouse tissue by RT-PCR analysis. 

Phrase: "RESULTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the gene expression of Ids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C1426909:Sulfatase 2 Gene [Gene or Genome]
   778   C0017262:Gene Expression [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in islets"

Phrase: "and"

Phrase: "exocrine mouse tissue by RT-PCR analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040300:Tissue [Tissue]
   748   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.108: Ids, insulin, and Iapp mRNA were specifically expressed in mouse pancreatic islets (Fig. 1A), but no signal was identified in exocrine tissue, which was positive for amylase. 

Phrase: "Ids,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Iapp mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   756   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]

Phrase: "were"

Phrase: "specifically"

Phrase: "expressed in mouse pancreatic islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   797   C1522528:Mouse Islets [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "identified in exocrine tissue,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0040300:Tissue [Tissue]
   770   C0205396:Identified [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "which"

Phrase: "was"

Phrase: "positive for amylase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439178:% Positive [Quantitative Concept]
   790   C1446409:Positive [Qualitative Concept]
   790   C1514241:Positive [Finding]
   790   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.109: To confirm the purity and specificity of the tissue samples, insulin and Iapp genes were used as positive controls for pancreatic islets and amylase gene for exocrine tissue. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]

Phrase: "and"

Phrase: "specificity of the tissue samples,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C2713393:Tissue Specificity [Organ or Tissue Function]
   762 E C1955394:Tissue specific [Body Substance]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Iapp genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017337:Genes [Gene or Genome]
   756   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   756   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]

Phrase: "were"

Phrase: "used as positive controls"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   799   C1883676:Positive Control [Conceptual Entity]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "for pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "amylase gene for exocrine tissue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.110: The housekeeping gene ribosomal protein S9 (Rps9) was used as internal control. 

Phrase: "The housekeeping gene ribosomal protein S9 (Rps9)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   884   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   853   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1622856:ribosomal protein [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0035553:Ribosomal [Cell Component]
   804   C1419029:S9 [Gene or Genome]
   804   C1861421:S9 [Gene or Genome]
   733 E C2984240:Ribosome [Functional Concept]

Phrase: "was"

Phrase: "used as internal control."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0597937:internal control [Mental Process]
   770   C0205102:Internal [Spatial Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1553872:Internal [Intellectual Product]
   770   C1619620:Internal [Intellectual Product]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.111: We also detected specific expression of Ids in the mouse pancreatic islet cell lines MIN6 and -TC1 (Fig. 1B). 

Phrase: "We also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "specific expression of Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the mouse pancreatic islet cell lines MIN6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   702   C1513528:Mouse Cell Line [Cell]
   700   C1522528:Mouse Islet Cell [Tissue]

Phrase: "and -"

Phrase: "TC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413028:TC1 [Gene or Genome]
  1000   C1420652:TC1 [Gene or Genome]
  1000   C1455542:TC1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.114: RT-PCR analysis demonstrated that murine iduronate-2-sulfatase (Ids) gene expression was specifically located in islets cells. 

Phrase: "RT-PCR analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0200931:PCR analysis [Laboratory Procedure]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "that murine iduronate-2-sulfatase (Ids) gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "specifically"

Phrase: "located in islets cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   819   C0022131:cells islets [Body Part, Organ, or Organ Component]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.115: A: mRNA from mouse islets and exocrine tissue extracts. 

Phrase: "A"

Phrase: ":"

Phrase: "mRNA from mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "exocrine tissue extracts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040291:Tissue Extracts [Biologically Active Substance]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
   793   C2828366:Extract [Substance]
Processing 00000000.tx.116: B: mRNA from MIN6 and -TC1 clonal cells. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "mRNA from MIN6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and -"

Phrase: "TC1 clonal cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0949431:TC1 Cells [Cell]
   865   C0009013:Clone Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.117: RT-PCR products of Ids, islet amyloid polypeptide (Iapp), insulin (Ins), amylase (Amy), glucagon (Gcg), and ribosomal protein S9 (Rps9) are shown. 

Phrase: "RT-PCR products of Ids,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "islet amyloid polypeptide (Iapp),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "insulin (Ins),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "amylase (Amy),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002712:Amylase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "glucagon (Gcg),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "ribosomal protein S9"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419029:S9 [Gene or Genome]
   827   C1861421:S9 [Gene or Genome]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "(Rps9"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0073341:ribosomal protein S9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419753:RIBOSOMAL PROTEIN S9 [Gene or Genome]
           S9
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419029:S9 [Gene or Genome]
   827   C1861421:S9 [Gene or Genome]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.118: Each PCR amplification was made without cDNA (CN), with reverse transcription sample (+), and, as a control, the sample without transcriptase enzyme (). 

Phrase: "Each PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "made without cDNA (CN),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1881534:Make [Functional Concept]

Phrase: "with reverse transcription sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "(+"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the sample without transcriptase enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.119: Sizes of specific bands are expressed in Table 1. 

Phrase: "Sizes of specific bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:SIZES [Spatial Concept]

Phrase: "are"

Phrase: "expressed in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.120: Ids, Iapp, and Ins mRNA are expressed in islet tissue, but not in exocrine cells, where Amy is specifically expressed. 

Phrase: "Ids,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Iapp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Ins mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "expressed in islet tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "but"

Phrase: "not in exocrine cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   816   C0734999:Exocrine cell [Cell]
   770   C0007634:Cells [Cell]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "where Amy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002712:Amylase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "specifically"

Phrase: "expressed."
Processing 00000000.tx.121: Ids is expressed in clonal islet cells, -cells (MIN6), and -cells (-TC1).  

Phrase: "Ids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "expressed in clonal islet cells, -"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   773 E C1522529:Islet Cell [Cell]
   762   C0009013:Clone Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1522642:Clonal [Tissue]
   760   C1704387:Clonal [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(MIN6"

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(-TC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413028:TC1 [Gene or Genome]
  1000   C1420652:TC1 [Gene or Genome]
  1000   C1455542:TC1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.122: Intracellular Localization of IDS The subcellular localization of the IDS protein COOH-terminally tagged with the enhanced green fluorescence protein (IDS-EGFP-N1) was studied in transiently transfected pancreatic -cells (MIN6). 

Phrase: "Intracellular Localization of IDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1660749:intracellular localization [Cell Function]
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "The subcellular localization of the IDS protein COOH-terminally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "tagged with the enhanced green fluorescence protein"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   835   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   757   C1818826:protein tag [Molecular Function]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332583:Green [Qualitative Concept]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   748   C2349975:Enhanced [Activity]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "(IDS-EGFP-N1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0441962:N1 [Finding]
   716   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "was"

Phrase: "studied in transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "transfected"

Phrase: "pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(MIN6"

Phrase: ")."
Processing 00000000.tx.123: The fusion protein was detected mainly in the lysosomes of all transfected cells (Fig. 2A), as shown by colocalization with the tetramethylrhodamine isothiocyanate-labeled lysosomal protein LAMP-2 (Fig. 2, B and C). 

Phrase: "The fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "mainly in the lysosomes of all transfected cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   744   C0007634:Cells [Cell]
   744   C0024369:Lysosomes [Cell Component]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2984253:Lysosome [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "shown by colocalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "with the tetramethylrhodamine isothiocyanate-labeled lysosomal protein LAMP-2"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   865   C1566771:Lysosomal-Associated Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C0065401:Lysosomal Membrane Proteins [Amino Acid, Peptide, or Protein,Immunologic Factor]
   854   C0065400:lysosomal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   842   C0230812:Lysosomal membrane [Cell Component]
   807   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0025255:Membrane [Tissue]
   791   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0332281:Associated [Qualitative Concept]
   791   C0596901:Membrane [Cell Component]
   791   C1706182:Membrane [Manufactured Object]
   758 E C0750490:Associate [Idea or Concept]
   758 E C1706221:Associate [Professional or Occupational Group]
   720 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.124: MIN6 cells expressing the green fluorescent protein (GFP) alone showed uniform labeling of the nucleus (data not shown). 

Phrase: "MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the green fluorescent protein (GFP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "uniform labeling of the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.126: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.127: Localization of IDS-EGFP to the lysosomal compartment in transfected MIN6 -cells. 

Phrase: "Localization of IDS-EGFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "to the lysosomal compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "in transfected MIN6 -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.128: A: enhanced green fluorescence protein (EGFP) localization of IDS in cytoplasmatic compartment. 

Phrase: "A"

Phrase: ":"

Phrase: "enhanced green fluorescence protein (EGFP) localization of IDS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0597704:protein localisation [Cell Function]
   778   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "in cytoplasmatic compartment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.129: B: localization of lysosomal-associated membrane protein (LAMP)-2, a lysosomal marker protein visualized with tetramethylrhodamine isothiocyanate (TRITC)-coupled antibodies (red). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "localization of lysosomal-associated membrane protein (LAMP)-2,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C1523225:membrane protein localization [Cell Function]
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
   738   C1819332:lysosome localisation [Biologic Function]
   731   C0125272:Lysosomal-Associated Membrane Protein 2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   731   C1416790:lysosomal-associated membrane protein 2 [Gene or Genome]

Phrase: "a lysosomal marker protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "visualized with tetramethylrhodamine isothiocyanate (TRITC)-coupled antibodies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0076308:tetramethylrhodamine isothiocyanate [Organic Chemical,Pharmacologic Substance]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0076306:tetramethylrhodamine [Organic Chemical,Pharmacologic Substance]
   753   C0124209:Isothiocyanate [Organic Chemical]
   753   C0206359:isothiocyanate [Organic Chemical]
   753   C0234621:Visualized [Functional Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.130: C: colocalization of LAMP-2 and IDS-EGFP (orange) by superimposition of A and B.  

Phrase: "C"

Phrase: ":"

Phrase: "colocalization of LAMP-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C1566771:Lysosome-Associated Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "IDS-EGFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   919   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   860   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(orange"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0440277:Orange [Food]
  1000   C0475654:orange [Food]
  1000   C1313858:Orange [Qualitative Concept]

Phrase: ")"

Phrase: "by superimposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0429562:Superimposition [Finding]

Phrase: "of A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.131: Effect of Glucose Metabolism on IDS and Perlecan mRNA Levels To determine whether Ids and perlecan gene expressions are regulated by metabolic signals, we investigated the effect of glucose on Ids and perlecan mRNA levels by using the quantitative real-time RT-PCR technique in mouse pancreatic islets cultured in different conditions for 24 h. 

Phrase: "Effect of Glucose Metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158774:glucose effect [Genetic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Perlecan mRNA Levels To"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "determine"

Phrase: "whether"

Phrase: "Ids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "perlecan gene expressions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expressions [Genetic Function]
   901   C2987154:Perlecan Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "regulated by metabolic signals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0311400:Metabolic [Functional Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1524026:Metabolic [Cell Function]
   770   C2707259:Metabolic [Clinical Attribute]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158774:glucose effect [Genetic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on Ids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
  1000   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   827   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "perlecan mRNA levels by"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the quantitative real-time RT-PCR technique in mouse pancreatic islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0449851:Technique [Functional Concept]

Phrase: "cultured in different conditions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1705242:Different [Qualitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0220814:culture [Functional Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C1705253:Condition [Conceptual Entity]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.132: When islets were cultured in different concentrations of glucose, the levels of Ids mRNA increased in a dose-dependent manner (Fig. 3A): 11.5, 40.2, 88, and 179% at 5.5, 11.1, 16.7, and 24.4 mM glucose, respectively. 

Phrase: "When"

Phrase: "islets"

Phrase: "were"

Phrase: "cultured in different concentrations of glucose,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C1705242:Different [Qualitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1446561:Concentration [Quantitative Concept]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "the levels of Ids mRNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased in a dose-dependent manner"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1512045:Dose-dependent [Quantitative Concept]
   783   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ":"

Phrase: "11.5,"

Phrase: "40.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "88,"

Phrase: "and"

Phrase: "179% at 5.5,"

Phrase: "11.1,"

Phrase: "16.7,"

Phrase: "and"

Phrase: "24.4 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.133: The increases at 16.7 and 24.4 mM glucose were statistically significant compared with islets cultured at 3 mM glucose (P < 0.01). 

Phrase: "The increases at 16.7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "24.4 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "compared with islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "cultured at 3 mM glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.134: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.136: Effect of glucose, various glucose analogs, and inhibitors on Ids (A), Iapp (B), Ins (C), and heparan sulfate proteoglycan 2 (Hspg2, D) mRNA expression in mouse islets. 

Phrase: "Effect of glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1158774:glucose effect [Genetic Function]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "various glucose analogs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0596619:glucose analog [Carbohydrate]
   827   C0243071:analogs [Chemical Viewed Structurally]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "and"

Phrase: "inhibitors on Ids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "Iapp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Ins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "heparan sulfate proteoglycan 2 (Hspg2, D) mRNA expression in mouse islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1515670:mRNA Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.137: Islets were incubated for 24 h in the presence of 3 mM (G3), 5.5 mM (G5), 11.1 mM (G11), 16.7 mM (G16), and 24.4 mM (G24) glucose, G3 + 1 mM glyceraldehyde (GL), G24 + 21.4 mM mannoheptulose (MH), and G3 + 21.4 mM 6-deoxyglucose (6DG). 

Phrase: "Islets"

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 3 mM (G3"

Phrase: ")"

Phrase: ","

Phrase: "5.5 mM (G5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1422272:G5 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "11.1 mM (G11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1420471:G11 [Gene or Genome]
   812   C3538702:G11 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "16.7 mM (G16"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "24.4 mM (G24"

Phrase: ")"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "G3 + 1 mM glyceraldehyde (GL),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017854:Glyceraldehyde [Carbohydrate]

Phrase: "G24 + 21.4 mM mannoheptulose (MH),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0024735:Mannoheptulose [Carbohydrate]

Phrase: "and"

Phrase: "G3 + 21.4 mM 6-deoxyglucose (6DG)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.138: Glucose (G16 and G24), but not other agents, significantly (P < 0.05) increased expression of Ids, Ins, and Iapp; 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G16"

Phrase: "and"

Phrase: "G24"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "other agents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased expression of Ids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Ins,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Iapp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.139: effects of glucose were blocked by mannoheptulose. 

Phrase: "effects of glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C1158774:glucose effect [Genetic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "blocked by mannoheptulose."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0024735:Mannoheptulose [Carbohydrate]
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.140: Hspg2 expression (D) was unaffected by glucose. 

Phrase: "Hspg2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "D)"

Phrase: "was"

Phrase: "unaffected by glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.141: mRNA levels are normalized to Rps18 mRNA expression. 

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "normalized to Rps18 mRNA expression."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0073319:ribosomal protein S18 [Amino Acid, Peptide, or Protein]
   814   C1419717:RIBOSOMAL PROTEIN S18 [Gene or Genome]
           S18
   778   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1515670:mRNA Expression [Genetic Function]
   778   C1622856:ribosomal protein [Genetic Function]
   774   C1171362:expression protein [Genetic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0035553:Ribosomal [Cell Component]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1882115:Normalized [Research Activity]
Processing 00000000.tx.142: Values are means  SE of 6 islet preparations examined in duplicate. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of 6 islet preparations"

Phrase: "examined in duplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0332128:Examined [Finding]
   790   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.143: *P < 0.05; 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.144: **P < 0.01 vs. 

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.145: G3.  

Phrase: "G3."
Processing 00000000.tx.146: To evaluate the effects of glucose metabolism on the expression of the Ids gene, we tested the effects of different glucose analogs and blocking agents (Fig. 3A). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the effects of glucose metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1158774:glucose effect [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the Ids gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017337:Gene [Gene or Genome]
   756   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   756   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effects of different glucose analogs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1158774:glucose effect [Genetic Function]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "blocking agents"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   861   C0233660:Blocking [Mental or Behavioral Dysfunction]
   861   C0332206:Blocking [Functional Concept]
   827 E C0028778:Block [Pathologic Function]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
   827 E C1533157:Block [Substance]
   827 E C1706084:Block [Geographic Area]
   827 E C2828370:Block [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.147: Neither glyceraldehyde (1 mM), which is incorporated into the glycolytic pathway, nor 6-deoxyglucose (21.4 mM), a glucose analog that is not phosphorylated by glucokinase, was able to produce an increase of the Ids mRNA levels. 

Phrase: "Neither glyceraldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017854:Glyceraldehyde [Carbohydrate]

Phrase: "(1 mM"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "incorporated into the glycolytic pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1512233:Glycolysis Pathway [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "nor"

Phrase: "6-deoxyglucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049551:6-deoxyglucose [Carbohydrate]
   861   C0011501:Deoxyglucose [Carbohydrate,Pharmacologic Substance]

Phrase: "(21.4 mM"

Phrase: ")"

Phrase: ","

Phrase: "a glucose analog"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0596619:glucose analog [Carbohydrate]
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "phosphorylated by glucokinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017713:Glucokinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415014:GLUCOKINASE [Gene or Genome]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "produce"

Phrase: "an increase of the Ids mRNA levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]
Processing 00000000.tx.148: Mannoheptulose (21.4 mM), a glucokinase inhibitor, completely blocked the effect of glucose (24 mM) on Ids mRNA levels. 

Phrase: "Mannoheptulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024735:Mannoheptulose [Carbohydrate]

Phrase: "(21.4 mM"

Phrase: ")"

Phrase: ","

Phrase: "a glucokinase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2246531:glucokinase inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the effect of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158774:glucose effect [Genetic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(24 mM) on Ids mRNA levels."
Processing 00000000.tx.149: Iapp, insulin, and perlecan gene expressions were analyzed in the same samples. 

Phrase: "Iapp,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "perlecan gene expressions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expressions [Genetic Function]
   901   C2987154:Perlecan Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "analyzed in the same samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.150: Whereas Iapp and insulin gene expressions increased with glucose (Fig. 3, B and C), there was no change of perlecan expression under any of the conditions (Fig. 3D). 

Phrase: "Whereas"

Phrase: "Iapp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "insulin gene expressions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expressions [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:expressions [Therapeutic or Preventive Procedure]

Phrase: "increased with glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   858   C0860803:glucose increased [Finding]
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C), there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "no change of perlecan expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "under any"

Phrase: "of the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.151: Insulin Content and Secretion of Transfected Islets To explore the role of IDS in mouse islets, islets were infected with lentivirus containing IDS constructs in sense and antisense orientation. 

Phrase: "Insulin Content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Secretion of Transfected Islets To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "explore"

Phrase: "the role of IDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in mouse islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "islets"

Phrase: "were"

Phrase: "infected with lentivirus containing IDS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0079679:Lentivirus [Virus]
   760   C0206037:Lentivirus [Virus]
   760   C0332256:Containing [Functional Concept]
   760   C0439663:Infected [Functional Concept]
   760   C2700400:Containing [Activity]

Phrase: "constructs in sense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036658:sense [Organ or Tissue Function]
   790   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "antisense orientation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1879714:Antisense Orientation [Functional Concept]
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.152: Figure 4 shows the IDS mRNA levels in infected islets. 

Phrase: "Figure 4"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the IDS mRNA levels in infected islets."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.153: The islet infection with lentivirus-EGFP did not affect IDS expression. 

Phrase: "The islet infection with lentivirus-EGFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0079680:Lentivirus Infection [Disease or Syndrome]
   742   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "IDS expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.154: However, when we infected the islets with the IDS sense construct, the gene expression increased 70% compared with noninfected islets (P < 0.05), and the islets infected with the IDS antisense construct showed a 43% reduction in the IDS gene expression in relation to noninfected islets (P < 0.05). 

Phrase: "However,"

Phrase: "when"

Phrase: "we"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "the islets with the IDS sense construct,"

Phrase: "the gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "70%"

Phrase: "compared with noninfected islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521118:Non-infected [Functional Concept]
   770   C1707455:Compared [Activity]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the islets"

Phrase: "infected with the IDS antisense construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439663:Infected [Functional Concept]
   753   C2827421:Construct [Classification]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 43% reduction in the IDS gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in relation to noninfected islets"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.155: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 4. 

Phrase: "4."
Processing 00000000.tx.157: Analysis of IDS mRNA expression by quantitative real-time RT-PCR in noninfected mouse pancreatic islets and islets infected with EGFP, IDS sense, and IDS antisense lentivirus constructions. 

Phrase: "Analysis of IDS mRNA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "by quantitative real-time RT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   911   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   888   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "in noninfected mouse pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1522528:Mouse Islets [Tissue]
   861   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "islets"

Phrase: "infected with EGFP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   864   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   809   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332583:Green [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C2349975:Enhanced [Activity]

Phrase: "IDS sense,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "IDS antisense lentivirus constructions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0441513:Construction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.158: mRNA levels are normalized to Rps18 mRNA expression. 

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "normalized to Rps18 mRNA expression."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0073319:ribosomal protein S18 [Amino Acid, Peptide, or Protein]
   814   C1419717:RIBOSOMAL PROTEIN S18 [Gene or Genome]
           S18
   778   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1515670:mRNA Expression [Genetic Function]
   778   C1622856:ribosomal protein [Genetic Function]
   774   C1171362:expression protein [Genetic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0035553:Ribosomal [Cell Component]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1882115:Normalized [Research Activity]
Processing 00000000.tx.159: IDS expression was significantly increased with IDS sense transfection and decreased in IDS antisense-infected islets. 

Phrase: "IDS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased with IDS sense transfection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0036658:sense [Organ or Tissue Function]
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "decreased in IDS antisense-infected islets."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.160: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.161: n = 3. 

Phrase: "n = 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.162: *P < 0.05.  

Phrase: "*P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.163: To determine the effects of IDS overexpression on islet function, insulin content and secretion of mouse islets infected with the lentiviruses at 20 plaque-forming units/ml (Table 2) were determined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of IDS overexpression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on islet function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion of mouse islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "infected with the lentiviruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0079679:Lentiviruses [Virus]
   770   C0439663:Infected [Functional Concept]
   737 E C0206037:Lentivirus [Virus]

Phrase: "at 20 plaque-forming units/ml (Table 2"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   845   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]
   801   C2945590:unit/mL [Quantitative Concept]
   795   C0011389:Plaque [Disease or Syndrome]
   795   C0039224:Table [Manufactured Object]
   795   C0205431:Forming [Functional Concept]
   795   C0332461:Plaque [Finding]
   795   C0333463:plaque [Acquired Abnormality]
   795   C0439148:Units [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   795   C1522492:Forming [Functional Concept]
   795   C1706073:Table [Medical Device]
   795   C1706074:Table [Intellectual Product]
   762 E C0348078:Form [Qualitative Concept]
   762 E C0376315:Form [Manufactured Object]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.164: The insulin content and secretory response were unaffected by infection with lentivirus-EGFP. 

Phrase: "The insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "secretory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "unaffected by infection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "with lentivirus-EGFP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   919   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   860   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.165: The insulin content of islets infected with the antisense IDS construct was reduced by 35% (P < 0.001) and 46% (P < 0.001) compared with noninfected islets cultured at 5.5 and 16.7 mM glucose, respectively. 

Phrase: "The insulin content of islets"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "infected with the antisense IDS construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439663:Infected [Functional Concept]
   753   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "reduced by 35%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "46%"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with noninfected islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521118:Non-infected [Functional Concept]
   770   C1707455:Compared [Activity]

Phrase: "cultured at 5.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "16.7 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.166: The increased insulin-secretory response of islets to high glucose (16.7 mM) was not affected by the presence of IDS in antisense or sense conformations (Table 2). 

Phrase: "The increased insulin-secretory response of islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "to high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(16.7 mM)"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the presence of IDS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "in antisense"

Phrase: "or"

Phrase: "sense conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: Any of the infected lentiviral constructions creates a cytotoxic effect, namely, apoptosis or necrosis, compared with the uninfected islet cells (Table 2). 

Phrase: "Any of the infected lentiviral constructions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439663:Infected [Functional Concept]
   753   C1552551:Any [Qualitative Concept]
   753   C3272371:ANY [Intellectual Product]
   719   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a cytotoxic effect,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   861   C1280500:Effect [Qualitative Concept]
   861   C1511636:cytotoxic [Functional Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "namely,"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or"

Phrase: "necrosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "compared with the uninfected islet cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   756 E C1522529:Islet Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.169: Insulin content, insulin secretion, and cell viability of mouse islets infected with EGFP, IDS sense, and IDS antisense lentivirus  Phenotypic Analysis of Transfected Islets The phenotype of infected pancreatic islets was studied by electron-microscopic analysis where immunogold labeling of IAPP was used to localize lysosomes and secretory granules. 

Phrase: "Insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "cell viability of mouse islets"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1522528:Mouse Islet Cell [Tissue]
   806   C0007620:Cell Viability [Cell Function]
   797   C0022131:cell islets [Body Part, Organ, or Organ Component]
   781 E C1522529:Islet Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0443348:viability [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "infected with EGFP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   864   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   809   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332583:Green [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C2349975:Enhanced [Activity]

Phrase: "IDS sense,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "IDS antisense lentivirus  Phenotypic Analysis of Transfected Islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "The phenotype of infected pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "was"

Phrase: "studied by electron-microscopic analysis where immunogold labeling of IAPP"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   761   C0026019:Electron microscopic study [Laboratory Procedure]
           Electron Microscopy
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0013852:Electron [Quantitative Concept]
   739   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
   739   C0205288:Microscopic [Qualitative Concept]
   739   C0936012:Analysis [Research Activity]
   739   C1167624:Labeling [Mental Process]
   739   C1415831:IAPP [Gene or Genome]
   739   C1524024:analysis [Functional Concept]
   739   C1947902:Labeling [Manufactured Object]
   739   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C3463986:Electron [Bird]
   724   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   706 E C0181496:Label [Manufactured Object]
   706   C0557651:Study [Manufactured Object]
   706   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "secretory granules."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.170: Electron-microscopic images reveal reactivity against IAPP in the lysosomes and secretory granules of all infected islets and controls (Fig. 5). 

Phrase: "Electron-microscopic images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "reactivity against IAPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205332:Reactive [Qualitative Concept]

Phrase: "in the lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "secretory granules of all infected islets"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0886515:Secretory Granules [Cell Component]
   756 E C3271154:Secretory Granule [Cell Component]
   753   C0010837:Granules [Cell Component]
   753   C0993609:Granules [Biomedical or Dental Material]
   753   C1327616:Secretory [Cell Function]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.171: No morphological cell changes were observed in noninfected islets (Fig. 5A) or islets infected with IDS sense (Fig. 5B). 

Phrase: "No morphological cell changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   846   C1260954:Morphologic change [Anatomical Abnormality]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in noninfected islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521118:Non-infected [Functional Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "or"

Phrase: "islets"

Phrase: "infected with IDS sense"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036658:sense [Organ or Tissue Function]
   770   C0439663:Infected [Functional Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.172: However, islets infected with IDS antisense presented modified cellular phenotype (Fig. 5C), characterized by an increase in lysosomal rate and size (Fig. 6). 

Phrase: "However,"

Phrase: "islets"

Phrase: "infected with IDS antisense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "modified cellular phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: ","

Phrase: "characterized by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1880022:Characterized [Activity]

Phrase: "in lysosomal rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.173: Interestingly, a higher rate of insulin granule degradation through crinophagic lysosomes could also be observed (Fig. 7). 

Phrase: "Interestingly,"

Phrase: "a higher rate of insulin granule degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "through crinophagic lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0024369:Lysosomes [Cell Component]
   827 E C2984253:Lysosome [Functional Concept]
   777 E C0521450:Lysosomal [Body Location or Region]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.174: View larger version (108K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(108K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.176: Electron micrograph of -cell of a pancreatic islet: immunogold labeling for IAPP in lysosomes and secretory granules. 

Phrase: "Electron micrograph of -cell of a pancreatic islet"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0734999:Pancreatic islet cell [Cell]
   789   C0030280:Pancreatic A-cell [Cell]
   767   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   767   C1522529:Islet Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "immunogold labeling for IAPP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C0181496:Label [Manufactured Object]

Phrase: "in lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "secretory granules."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.177: A: noninfected islets. 

Phrase: "A"

Phrase: ":"

Phrase: "noninfected islets."
Processing 00000000.tx.178: B: islets infected with IDS sense. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "islets"

Phrase: "infected with IDS sense."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036658:sense [Organ or Tissue Function]
   770   C0439663:Infected [Functional Concept]
Processing 00000000.tx.179: C: islets infected with IDS antisense.  

Phrase: "C"

Phrase: ":"

Phrase: "islets"

Phrase: "infected with IDS antisense."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]
Processing 00000000.tx.180: View larger version (114K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(114K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.181: 6. 

Phrase: "6."
Processing 00000000.tx.182: Electron micrographs of -cell of a pancreatic islet infected with IDS antisense. 

Phrase: "Electron micrographs of -cell of a pancreatic islet"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0734999:Pancreatic islet cell [Cell]
   789   C0030280:Pancreatic A-cell [Cell]
   767   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   767   C1522529:Islet Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "infected with IDS antisense."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]
Processing 00000000.tx.183: Note large lysosomes containing several vacuoles in AC.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "large lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0024369:Lysosomes [Cell Component]
   827 E C2984253:Lysosome [Functional Concept]
   777 E C0521450:Lysosomal [Body Location or Region]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "several vacuoles in AC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0042219:Vacuoles [Cell Component]
Processing 00000000.tx.184: View larger version (118K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 7. 

Phrase: "7."
Processing 00000000.tx.186: Electron micrographs of -cell of a pancreatic islet infected with IDS antisense. 

Phrase: "Electron micrographs of -cell of a pancreatic islet"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0734999:Pancreatic islet cell [Cell]
   789   C0030280:Pancreatic A-cell [Cell]
   767   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   767   C1522529:Islet Cell [Cell]
   744   C0007634:Cell [Cell]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "infected with IDS antisense."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]
Processing 00000000.tx.187: Note crinophagic bodies in A and B.   

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "crinophagic bodies in A"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.188: DISCUSSION TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  In this study, we demonstrate the presence of Ids in - and -pancreatic cells. 

Phrase: "DISCUSSION TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "the presence of Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "and -"

Phrase: "pancreatic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.189: Our findings confirm the results of previous preliminary reports that detected the presence of IDS in several tissues, including pancreatic cells, by differential display and Northern blot analysis (12, 24). 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the results of previous preliminary reports"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1548161:Preliminary results [Idea or Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "that"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the presence of IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in several tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "pancreatic cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by differential display"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887824:Differential Display [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705417:Display [Manufactured Object]

Phrase: "and"

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "(12,"

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.190: IDS is a component of lysosomes in fibroblasts (22). 

Phrase: "IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a component of lysosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449432:Component [Manufactured Object]
   770   C1705248:Component [Conceptual Entity]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.191: To confirm the specific localization in islet cells and avoid contamination of islet extracts with fibroblasts, expression of Ids was identified by PCR analysis in pure clonal cells such as MIN6 (a cell line derived from an insulinoma of transgenic mice) and -TC1 cells (from a pancreatic adenoma created in transgenic mice). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specific localization in islet cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "avoid"

Phrase: "contamination of islet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0259846:contamination [Human-caused Phenomenon or Process]
   790   C1881659:CONTAMINATION [Event]
   790   C2349974:Contamination [Idea or Concept]

Phrase: "extracts with fibroblasts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016030:Fibroblasts [Cell]
   790   C2828366:Extract [Substance]

Phrase: "expression of Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "identified by PCR analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0200931:PCR analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0205396:Identified [Qualitative Concept]
   770   C0677874:pCR [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "in pure clonal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   865   C0009013:Clone Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "such as MIN6"

Phrase: "(a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "derived from an insulinoma of transgenic mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0025936:Mice, Transgenic [Mammal]
   757   C1522248:Mouse Insulinoma [Neoplastic Process]
   748   C0003069:Transgenic [Animal]
   748   C0021670:insulinoma [Neoplastic Process]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "and -"

Phrase: "TC1 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0949431:TC1 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "from a pancreatic adenoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1142432:Pancreatic adenoma [Neoplastic Process]
   861   C0001430:Adenoma [Neoplastic Process]

Phrase: "created in transgenic mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1706214:Created [Activity]
   737 E C3244320:create [Functional Concept]

Phrase: ")."
Processing 00000000.tx.192: IDS was identified at intracellular sites in lysosomes by transfection of MIN6 cells with the GFP construct (IDS-EGPF), which is in agreement with previous studies on other cell types, such as fibroblast and neuronal cells (8, 22, 38). 

Phrase: "IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "identified at intracellular sites"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0205145:Sites [Spatial Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "by transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of MIN6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with the GFP construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827421:Construct [Classification]
   756   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(IDS-EGPF"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "on other cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "such as fibroblast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblast [Cell]

Phrase: "and"

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(8,"

Phrase: "22,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.193: The role of IDS activity in the pancreatic -cell is not known, but it could be involved in the degradation of HSPG2 (perlecan), which has been identified in pancreatic islet cells (41). 

Phrase: "The role of IDS activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the pancreatic -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "involved in the degradation of HSPG2"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   818   C0136134:heparan sulfate proteoglycan 2 [Amino Acid, Peptide, or Protein]
   818   C1415793:heparan sulfate proteoglycan 2 [Gene or Genome]
   810   C1157789:heparan sulfate proteoglycan degradation [Molecular Function]
   790   C0062503:Heparan Sulfate Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   764   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   764   C1418889:PROTEOGLYCAN 2 [Gene or Genome]
   762   C1157788:proteoglycan degradation [Molecular Function]
   742   C0033692:Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0038720:Sulfate [Inorganic Chemical]
   742   C0243125:degradation [Functional Concept]
   742   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   742   C0699900:Degradation [Organism Function]
   742   C1314939:Involved [Functional Concept]
   742   C2327880:Heparan [Biologically Active Substance]
   742   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "identified in pancreatic islet cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   845   C0734999:Pancreatic islet cell [Cell]
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   797   C0805527:Cells identified [Laboratory or Test Result]
   773 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.194: Recent studies have demonstrated that pancreatic islet -cells synthesize and secrete predominantly HSPGs, and these proteoglycans bind to human amylin (32). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that pancreatic islet -cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   983   C0734999:Pancreatic islet cell [Cell]
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "synthesize"

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "predominantly HSPGs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0062503:HSPG [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1419892:HSPG [Gene or Genome]
   827   C2987155:HSPG [Amino Acid, Peptide, or Protein]
   827   C3540635:HSPG [Gene or Genome]

Phrase: "and"

Phrase: "these proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind to human amylin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0086418:Human [Human]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1415831:AMYLIN [Gene or Genome]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.195: Perlecan is a member of the HSPG family that is present in the basement membrane of several vascularized organs, and it has been implicated in complications such as diabetic nephropathy (17). 

Phrase: "Perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a member of the HSPG family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "is"

Phrase: "present in the basement membrane of several vascularized organs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0009566:Complications [Pathologic Function]
   790   C1171258:complications [Pathologic Function]
   756 E C2362589:Complication [Idea or Concept]
   706 E C0231242:Complicated [Functional Concept]

Phrase: "such as diabetic nephropathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.196: Perlecan is also a component of amyloid deposits described in type 2 diabetes (13), together with other proteins such as apolipoprotein E (37) and the main component, the IAPP amylin. 

Phrase: "Perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "also"

Phrase: "a component of amyloid deposits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1440087:Amyloid A component [Immunologic Factor]
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "described in type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "together with other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "the main component,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "the IAPP amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.197: The accumulation of islet amyloid in the pancreas is pathogenic in diabetes, because it leads to progressive deterioration and death by apoptosis of -cells (15). 

Phrase: "The accumulation of islet amyloid"

Phrase: "in the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "pathogenic in diabetes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0450254:Pathogenic [Organism]
   718 E C0030657:pathogenicity [Qualitative Concept]
   718 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "because"

Phrase: "it"

Phrase: "leads to progressive deterioration"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0205329:Progressive [Functional Concept]
   770   C0868945:Deterioration [Phenomenon or Process]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "death by apoptosis of -cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0162638:apoptotic cell death [Cell Function]
   797   C0007587:cells death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.198: Perlecan binds to the NH2-terminal site of the human pro-IAPP, which enhances IAPP fibril formation in vitro (20). 

Phrase: "Perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "binds to the NH2-terminal site of the human pro-IAPP,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   756   C2945843:Site of [Qualitative Concept]
   738   C0002508:NH2 [Organic Chemical]
   738   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   738   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
   738   C0086418:Human [Human]
   738   C0205088:Terminal [Temporal Concept]
   738   C0205145:Site [Spatial Concept]
   738   C1145667:Bind [Activity]
   738   C1167622:bind [Molecular Function]
   738   C1415831:IAPP [Gene or Genome]
   738   C1515974:Site [Body Location or Region]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C2825164:Site [Spatial Concept]
   738   C2987124:PRO [Intellectual Product]

Phrase: "which"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "IAPP fibril formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2247818:IAPP formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.199: Furthermore, several studies have identified the NH2-terminal region of pro-IAPP in amyloid deposits of diabetic pancreas (5, 39). 

Phrase: "Furthermore,"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the NH2-terminal region of pro-IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "in amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits of diabetic pancreas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C0241863:DIABETIC [Finding]
   770   C0333562:Deposit [Functional Concept]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.200: The role of IDS in islet amyloid formation is unclear, however, partly because of the difficulty of measurement of IDS enzymatic activity in -cells. 

Phrase: "The role of IDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in islet amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "unclear, however,"

Phrase: "partly because of the difficulty of measurement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0242485:Measurement [Functional Concept]
   748   C1299586:Difficulty [Finding]

Phrase: "of IDS enzymatic activity in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.201: IDS expression is regulated by signals from glucose metabolism, as expression is dependent on glucose concentrations and phosphorylation and glycolysis. 

Phrase: "IDS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756   C1710082:Signal [Phenomenon or Process]

Phrase: "from glucose metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "as"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "dependent on glucose concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "glycolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]
Processing 00000000.tx.202: However, glucose did not affect the expression of perlecan. 

Phrase: "However,"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of perlecan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.203: A decrease of perlecan mRNA was observed in adipocytes and in glomerular epithelial cells from rat and diabetic mice cultured in high-glucose conditions (21, 31, 33). 

Phrase: "A decrease of perlecan mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206131:Adipocytes [Cell]
   790   C1441672:Observed [Functional Concept]

Phrase: "and in glomerular epithelial cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0014597:Epithelial Cells [Cell]
   806   C1273342:Epithelial Cells [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0022663:Glomerular [Body Part, Organ, or Organ Component]
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0268731:GLOMERULAR [Disease or Syndrome]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "from rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "diabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "cultured in high-glucose conditions"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0860803:high glucose [Finding]
   781   C0680299:high culture [Population Group]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0220814:culture [Functional Concept]
   726   C0348080:Condition [Qualitative Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C1705253:Condition [Conceptual Entity]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(21,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.204: Such differences in regulation of enzyme and substrate could be attributed to the differences in cell type or the fact that the transcriptional and/or posttranscriptional mechanisms of IDS and perlecan are regulated on different time scales. 

Phrase: "Such differences in regulation of enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "could"

Phrase: "be"

Phrase: "attributed to the differences in cell type"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   757   C0332307:Type - attribute [Qualitative Concept]
           Type
   757   C3539097:Attribute type [Intellectual Product]
   748   C1269647:Cell [Cell]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "or"

Phrase: "the fact"

Phrase: "that"

Phrase: "the transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and/or"

Phrase: "posttranscriptional mechanisms of IDS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "perlecan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "regulated on different time scales."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0175659:Scales [Medical Device]
   760   C0222045:Scales [Body Part, Organ, or Organ Component]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C0349674:Scale [Intellectual Product]
   726 E C1947916:Scale [Activity]
   726 E C3536777:Scale [Manufactured Object]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.205: The same pattern of regulation of IAPP has been previously described by our group (14, 29). 

Phrase: "The same pattern of regulation of IAPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described by our group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "(14,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.206: Overexpression of IDS had no effect on glucose-stimulated insulin secretion. 

Phrase: "Overexpression of IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "had"

Phrase: "no effect on glucose-stimulated insulin secretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1301751:No effect [Qualitative Concept]
   774   C1158774:glucose effect [Genetic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.207: However, inhibition of IDS expression resulted in decreased cellular insulin content. 

Phrase: "However,"

Phrase: "inhibition of IDS expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "resulted in decreased cellular insulin content."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   753   C0007634:Cellular [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178539:Cellular [Functional Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0423896:Content [Mental Process]
   753   C0442797:decreased [Qualitative Concept]
   753   C0456205:Content [Conceptual Entity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C0547047:Decrease [Quantitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.208: Lysosomal activity in -cells includes degradation of insulin granules that are not directed to the secretory pool. 

Phrase: "Lysosomal activity in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "degradation of insulin granules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "that"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "directed to the secretory pool."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0337051:Pool [Geographic Area]
   760   C1327616:Secretory [Cell Function]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.209: This process is known as crinophagy (9). 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "known as crinophagy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205309:Known [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.210: Proteolytic enzymes, including cathepsin, degrade insulin, IAPP, and other granule peptides (1). 

Phrase: "Proteolytic enzymes,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0030940:Proteolytic Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1947941:Proteolytic Enzyme [Enzyme]
           proteolytic
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   861   C0597304:Proteolytic [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cathepsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "degrade"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IAPP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: "and"

Phrase: "other granule peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.211: Inhibition of lysosomal enzymes results in increased lysosomal size and population (2). 

Phrase: "Inhibition of lysosomal enzymes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0877008:enzyme inhibition [Disease or Syndrome]
   802   C1524081:Enzyme Inhibition [Physiologic Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "results in increased lysosomal size"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332509:Increased size [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0456389:size [Spatial Concept]
   760   C0521450:Lysosomal [Body Location or Region]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.212: The inhibition of the lysosomal enzyme IDS by antisense transfection results in increased lysosomal size and increased degradation of insulin granules via the crinophagic pathway, as has been also proposed (34). 

Phrase: "The inhibition of the lysosomal enzyme IDS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0877008:enzyme inhibition [Disease or Syndrome]
   774   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by antisense transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "results in increased lysosomal size"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332509:Increased size [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0456389:size [Spatial Concept]
   760   C0521450:Lysosomal [Body Location or Region]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "increased degradation of insulin granules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "via the crinophagic pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "also"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.213: However, if IDS is impaired, it does not necessarily mean that other lysosomal activities, such as those for protein degradation, are inhibited. 

Phrase: "However,"

Phrase: "if"

Phrase: "IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: ","

Phrase: "it"

Phrase: "does"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "other lysosomal activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "such as those for protein degradation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "are"

Phrase: "inhibited."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.214: Direct studies of intracellular insulin degradation are needed to clarify this question. 

Phrase: "Direct studies of intracellular insulin degradation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "this question."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]
Processing 00000000.tx.215: With this restriction in mind, we suggest that the decreased insulin content in antisense transfected islets is due to the effect of IDS decrease on the lysosomal activity. 

Phrase: "With this restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restriction [Functional Concept]

Phrase: "in mind,"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0229992:Mind, NOS [Mental Process]
   944 E C0229993:Psychic [Functional Concept]
   916 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   916 E C0042241:DIAPHRAGM [Medical Device]
   916 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   916 E C1705367:Diaphragm [Medical Device]
   900 E C0086045:mindfulness [Mental Process]
   900 E C3542996:Mindfulness [Mental Process]

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decreased insulin content in antisense transfected islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is due to the effect of IDS decrease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "on the lysosomal activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.216: The insulin-secretory response, however, was not affected by enzyme inhibition, because the release of insulin would be expected to be maintained in this short period of time. 

Phrase: "The insulin-secretory response,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "however,"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by enzyme inhibition,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0877008:enzyme inhibition [Disease or Syndrome]
   833   C1524081:Enzyme Inhibition [Physiologic Function]
   770   C0014442:Enzyme [Enzyme,Organic Chemical]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737 E C0001721:Affect [Mental Process]

Phrase: "because"

Phrase: "the release of insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "maintained in this short period of time."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0425946:short period [Finding]
   774   C0439582:Time period [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1282927:short [Qualitative Concept]
   748   C1314677:Maintained [Functional Concept]
   748   C1806781:Short [Quantitative Concept]
   748   C1948053:Period [Temporal Concept]
   748   C2350002:Short [Quantitative Concept]
   748   C3541383:Time [Temporal Concept]
   714 E C0024501:Maintain [Activity]
Processing 00000000.tx.217: In conclusion, we have demonstrated that IDS is localized to lysosomes and normally expressed in mouse pancreatic islets. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that IDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "localized to lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C0392752:Localized [Spatial Concept]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "normally"

Phrase: "expressed in mouse pancreatic islets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   797   C1522528:Mouse Islets [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.218: Expression is regulated by signals from glucose metabolism. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756   C1710082:Signal [Phenomenon or Process]

Phrase: "from glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.219: Lentivirus-mediated inhibition of IDS expression in pancreatic islets decreased the insulin content via the crinophagic pathway.  

Phrase: "Lentivirus-mediated inhibition of IDS expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the insulin content via the crinophagic pathway."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C2984427:Insulin Pathway [Functional Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.220: GRANTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  This work has been supported by Fondo de Investigaciones Sanitarias Grants 99/0378 and 02/931, Fundaci Marat TV3 Grant 1998/991730/31/32, Red de Centros Grant C03/08, and Red de Grupos de Diabetes Grant G03/212 from Ministerio de Sanidad y Consumo. 

Phrase: "GRANTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "been"

Phrase: "supported by Fondo de Investigaciones Sanitarias Grants 99/0378"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   742   C0011198:DE [Geographic Area]
   742   C0017480:DE [Geographic Area]
   742   C0018173:Grants [Quantitative Concept]
   742   C1521721:Supported [Conceptual Entity]
   742   C3541240:DE [Idea or Concept]
   708 E C0183683:Support [Medical Device]
   708 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "02/931,"

Phrase: "Fundaci Marat TV3 Grant 1998/991730/31/32,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0018173:Grant [Quantitative Concept]
   793   C0450355:31 [Intellectual Product]
   793   C1548284:Grant [Idea or Concept]

Phrase: "Red de Centros Grant C03/08,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0011198:DE [Geographic Area]
   799   C0017480:DE [Geographic Area]
   799   C0018173:Grant [Quantitative Concept]
   799   C0332575:Red [Finding]
   799   C1260956:Red [Qualitative Concept]
   799   C1548284:Grant [Idea or Concept]
   799   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "Red de Grupos de Diabetes Grant G03/212"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0011198:DE [Geographic Area]
   793   C0011847:Diabetes [Disease or Syndrome]
   793   C0011849:Diabetes [Disease or Syndrome]
   793   C0017480:DE [Geographic Area]
   793   C0018173:Grant [Quantitative Concept]
   793   C0332575:Red [Finding]
   793   C1260956:Red [Qualitative Concept]
   793   C1548284:Grant [Idea or Concept]
   793   C3541240:DE [Idea or Concept]

Phrase: "from Ministerio de Sanidad y Consumo."
Processing 00000000.tx.221: A. 

Phrase: "A."
Processing 00000000.tx.222: Clark is supported by the Wellcome Trust.  

Phrase: "Clark"

Phrase: "is"

Phrase: "supported by the Wellcome Trust."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0237935:Trust [Individual Behavior]
   760   C1521721:Supported [Conceptual Entity]
   760   C3245466:trust [Idea or Concept]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.223: FOOTNOTES  Address for reprint requests and other correspondence: R. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.224: Gomis, Dept. of Endocrinology and Diabetes, Hospital Clinic de Barcelona, c/Villarroel, 170, 08036 Barcelona, Spain (E-mail: gomis{at}medicina.ub.es ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "Gomis,"

Phrase: "Dept."

Phrase: "of Endocrinology"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   928 E C0694557:endocrinologic [Functional Concept]

Phrase: "and"

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Hospital Clinic de Barcelona,"

Phrase: "c/Villarroel,"

Phrase: "170,"

Phrase: "08036 Barcelona,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gomis{at}medicina.ub.es )"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.225: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.226: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.227: REFERENCES TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Authier F, Rachubinski RA, Posner BI, and Bergeron JJ. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "and"

Phrase: "Bergeron JJ."
Processing 00000000.tx.228: Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.229: J Biol Chem 269: 30103016, 1994.[Abstract/Free FullText] Bhogal RK, Novials A, Nilsson MR, Coronado I, Gomis R, Gray D, Morris JF, and Clark A. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016,"

Phrase: "1994."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bhogal RK,"

Phrase: "Novials A,"

Phrase: "Nilsson MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Coronado I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gray D,"

Phrase: "Morris JF,"

Phrase: "and"

Phrase: "Clark A."
Processing 00000000.tx.230: Islet amyloid polypeptide (IAPP) accumulates in lysosomes of human beta-cells by crinophagy but does not form fibrils (Abstract). 

Phrase: "Islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: ")"

Phrase: "accumulates in lysosomes of human beta-cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0024369:Lysosomes [Cell Component]
   748   C0086418:Human [Human]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C2004068:Beta [Qualitative Concept]
   748   C3282337:Cells [Cell]
   745   C0030281:Beta cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2984253:Lysosome [Functional Concept]

Phrase: "by crinophagy"

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.231: Diabetologia 45, Suppl 2: A144, 2002. 

Phrase: "Diabetologia 45,"

Phrase: "Suppl 2"

Phrase: ":"

Phrase: "A144,"

Phrase: "2002."
Processing 00000000.tx.232: Castillo GM, Cummings JA, Yang W, Judge ME, Sheardown MJ, Rimvall K, Hansen JB, and Snow AD. 

Phrase: "Castillo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Cummings JA,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "W,"

Phrase: "Judge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221191:Judge [Professional or Occupational Group]

Phrase: "ME,"

Phrase: "Sheardown MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Rimvall K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hansen JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "and"

Phrase: "Snow AD."
Processing 00000000.tx.233: Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. 

Phrase: "Sulfate content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "specific glycosaminoglycan backbone of perlecan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037949:Backbone [Body Part, Organ, or Organ Component]
   760   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "critical for perlecan's enhancement of islet amyloid polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1511545:Critical [Qualitative Concept]

Phrase: "(amylin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]

Phrase: ")"

Phrase: "fibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.234: Diabetes 47: 612620, 1998.[Abstract] Chirgwin JM, Przybyla AE, MacDonald RJ, and Rutter WJ. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "612620,"

Phrase: "1998."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chirgwin JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Przybyla AE,"

Phrase: "MacDonald RJ,"

Phrase: "and"

Phrase: "Rutter WJ."
Processing 00000000.tx.235: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. 

Phrase: "Isolation of biologically active ribonucleic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "from sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]

Phrase: "enriched in ribonuclease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0359583:enriched [Food]
Processing 00000000.tx.236: Biochemistry 18: 52945299, 1979.[ISI][Medline] Clark A, de Koning EJP, Baker CA, Charg S, and Morris JF. 

Phrase: "Biochemistry 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "52945299,"

Phrase: "1979."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clark A,"

Phrase: "de Koning EJP,"

Phrase: "Baker CA,"

Phrase: "Charg S,"

Phrase: "and"

Phrase: "Morris JF."
Processing 00000000.tx.237: Localization of N-terminal pro-islet amyloid polypeptide in beta cells of man and transgenic mice (Abstract). 

Phrase: "Localization of N-terminal pro-islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "in beta cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "of man"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.238: Diabetologia 36: A136, 1993. 

Phrase: "Diabetologia 36"

Phrase: ":"

Phrase: "A136,"

Phrase: "1993."
Processing 00000000.tx.239: Conde-Knape K. 

Phrase: "Conde-Knape K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.240: Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. 

Phrase: "Heparan sulfate proteoglycans in experimental models of diabetes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0062503:Heparan Sulfate Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   767 E C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   744   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C2327880:Heparan [Biologically Active Substance]
   744   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "a role for perlecan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in diabetes complications."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetes Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.241: Diabetes Metab Res 17: 412421, 2001.[CrossRef][ISI] Cooper CJS, Willis AC, Clark A, Turner RC, Sim RB, and Reid KBM. 

Phrase: "Diabetes Metab Res 17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "412421,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Cooper CJS,"

Phrase: "Willis AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Clark A,"

Phrase: "Turner RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Sim RB,"

Phrase: "and"

Phrase: "Reid KBM."
Processing 00000000.tx.242: Purification and characterization of a peptide from amyloid-rich pancreas of type 2 diabetic patients. 

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "from amyloid-rich pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of type 2 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.243: Proc Natl Acad Sci USA 84: 86288631, 1987.[Abstract] Daniele A, Tomanin R, Villani GRD, Zacchello F, Scarpa M, and Di Natale P. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "86288631,"

Phrase: "1987."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Daniele A,"

Phrase: "Tomanin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Villani GRD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018213:GRD [Disease or Syndrome]
   861   C0018232:GRD [Geographic Area]

Phrase: "Zacchello F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Scarpa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Di Natale P."
Processing 00000000.tx.244: Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro. 

Phrase: "Uptake of recombinant iduronate-2-sulfatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "into neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.245: Biochim Biophys Acta 1588: 203209, 2002.[ISI][Medline] De Duve C. 

Phrase: "Biochim Biophys Acta 1588"

Phrase: ":"

Phrase: "203209,"

Phrase: "2002."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Duve C."
Processing 00000000.tx.246: The lysosome in retrospect. 

Phrase: "The lysosome in retrospect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024369:Lysosome [Cell Component]
   770   C2984253:Lysosome [Functional Concept]
Processing 00000000.tx.247: In: Lysosomes in Biology and Pathology, edited by Dingle JT and Fell HB. 

Phrase: "In"

Phrase: ":"

Phrase: "Lysosomes in Biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0024369:Lysosomes [Cell Component]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "edited by Dingle JT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0868955:Edit [Occupational Activity]

Phrase: "and"

Phrase: "Fell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0085639:Fall [Finding]
   966   C0238715:Fall [Temporal Concept]

Phrase: "HB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Hb [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.248: Amsterdam: North Holland, 1969, vol. 

Phrase: "Amsterdam"

Phrase: ":"

Phrase: "North Holland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027778:Holland [Geographic Area]

Phrase: "1969,"

Phrase: "vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.249: 1, p. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.250: 340. 

Phrase: "340."
Processing 00000000.tx.251: Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, and Thorens B. 

Phrase: "Dupraz P,"

Phrase: "Rinsch C,"

Phrase: "Pralong WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Rolland E,"

Phrase: "Zufferey R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Trono D,"

Phrase: "and"

Phrase: "Thorens B."
Processing 00000000.tx.252: Lentivirus-mediated Bcl-2 expression in TC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. 

Phrase: "Lentivirus-mediated Bcl-2 expression in TC-tet cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "improves"

Phrase: "resistance to hypoxia"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C0332325:Resistant to [Functional Concept]
       E   Resistant
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "cytokine-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "while"

Phrase: "preserving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0728887:Preserving [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "control of insulin secretion."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1550141:Control [Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.253: Gene Ther 6: 11601169, 1999.[CrossRef][ISI][Medline] Ferrer J, Wasson J, Schoor K, Muecker M, Donis-Keller H, and Permutt A. 

Phrase: "Gene Ther 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "11601169,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferrer J,"

Phrase: "Wasson J,"

Phrase: "Schoor K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Muecker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Donis-Keller H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Permutt A."
Processing 00000000.tx.254: Mapping novel pancreatic islet genes to human chromosomes. 

Phrase: "Mapping"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1283195:Mapping [Activity]
   966 E C0024779:Map [Manufactured Object]
   966 E C1706473:Map [Conceptual Entity]

Phrase: "novel pancreatic islet genes to human chromosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0314604:genes human [Gene or Genome]
   748   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.255: Diabetes 46: 386392, 1997.[Abstract] Flomen RH, Green PM, Bentley DR, and Giannell F. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "386392,"

Phrase: "1997."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Flomen RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Green PM, Bentley DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0031831:DR [Professional or Occupational Group]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]

Phrase: "and"

Phrase: "Giannell F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.256: Determination of the organization of coding sequences within the iduronate sulfatase (IDS) gene. 

Phrase: "Determination of the organization of coding sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0917791:Sequence Determination [Laboratory Procedure,Molecular Biology Research Technique]
   748   C1148554:determination [Laboratory Procedure]

Phrase: "within the iduronate sulfatase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020814:Iduronate Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0684201:Iduronate [Biologically Active Substance,Carbohydrate]

Phrase: "(IDS) gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415882:IDS gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.257: Hum Mol Genet 2: 510, 1993.[Abstract] Froissart R, Millart G, Mathieu M, Bozon D, and Marie I. 

Phrase: "Hum Mol Genet 2"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "510,"

Phrase: "1993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Froissart R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Millart G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mathieu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bozon D,"

Phrase: "and"

Phrase: "Marie I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.258: Processing of iduronate-2-sulfatase in human fibroblast. 

Phrase: "Processing of iduronate-2-sulfatase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "in human fibroblast."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblast [Cell]
Processing 00000000.tx.259: Biochem J 309: 425430, 1995.[ISI][Medline] Gasa R, Gomis R, Casamitjana R, Rivera F, and Novials A. 

Phrase: "Biochem J 309"

Phrase: ":"

Phrase: "425430,"

Phrase: "1995."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gasa R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gomis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Casamitjana R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rivera F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Novials A."
Processing 00000000.tx.260: Glucose regulation of islet amyloid polypeptide gene expression in rat pancreatic islets. 

Phrase: "Glucose regulation of islet amyloid polypeptide gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "in rat pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.261: Am J Physiol Endocrinol Metab 272: E543E549, 1997.[Abstract/Free FullText] Gebre-Medhin S, Olofsson C, and Mulder H. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 272"

Phrase: ":"

Phrase: "E543E549,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gebre-Medhin S,"

Phrase: "Olofsson C,"

Phrase: "and"

Phrase: "Mulder H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.262: Islet amyloid polypeptide in the islet of Langerhans: friend or foe? 

Phrase: "Islet amyloid polypeptide in the islet of Langerhans"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   800   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   793   C0022131:Islet of Langerhans [Body Part, Organ, or Organ Component]
           islet langerhans
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "friend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "or"

Phrase: "foe?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823656:FOE [Gene or Genome]
Processing 00000000.tx.263: Diabetologia 43: 687695, 2000.[CrossRef][ISI][Medline] Hart M, Li L, Tokunaga T, Lindsey JR, Hassell JR, Snow AD, and Fukuchi K. 

Phrase: "Diabetologia 43"

Phrase: ":"

Phrase: "687695,"

Phrase: "2000."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Li L,"

Phrase: "Tokunaga T,"

Phrase: "Lindsey JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Hassell JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Snow AD,"

Phrase: "and"

Phrase: "Fukuchi K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.264: Overproduction of perlecan core protein in cultured cells and transgenic mice. 

Phrase: "Overproduction of perlecan core protein"

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.265: J Pathol 194: 262269, 2001.[CrossRef][ISI][Medline] Hopwood JJ. 

Phrase: "J Pathol 194"

Phrase: ":"

Phrase: "262269,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hopwood JJ."
Processing 00000000.tx.266: Enzymes that degrade heparin and heparan sulphate. 

Phrase: "Enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "degrade"

Phrase: "heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "heparan sulphate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C2327880:Heparan [Biologically Active Substance]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.267: In: Heparin: Chemical and Biological Properties, Clinical Applications, edited by Lane DW and Lindahl U. 

Phrase: "In"

Phrase: ":"

Phrase: "Heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "and"

Phrase: "Biological Properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "Clinical Applications,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0185125:applications [Health Care Activity]
   827 E C1947919:Application [Intellectual Product]
   827 E C2347934:Application [Intellectual Product]
   827 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "edited by Lane DW"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   737   C0868955:Edit [Occupational Activity]

Phrase: "and"

Phrase: "Lindahl U."
Processing 00000000.tx.268: London: Arnold, 1989, p. 

Phrase: "London"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: ":"

Phrase: "Arnold,"

Phrase: "1989,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.269: 190229. 

Phrase: "190229."
Processing 00000000.tx.270: Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, and Gal A. 

Phrase: "Hopwood JJ,"

Phrase: "Bunge S,"

Phrase: "Morris CP,"

Phrase: "Wilson PJ,"

Phrase: "Steglich C,"

Phrase: "Beck M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schwinger E,"

Phrase: "and"

Phrase: "Gal A."
Processing 00000000.tx.271: Molecular basis of mucopolysaccharidosis type II mutations in the iduronate-2-sulphatase gene. 

Phrase: "Molecular basis of mucopolysaccharidosis type II mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1853126:MOLECULAR BASIS [Idea or Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "in the iduronate-2-sulphatase gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017337:Gene [Gene or Genome]
   756   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   756   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
Processing 00000000.tx.272: Hum Mutat 2: 435442, 1993.[ISI][Medline] Hopwood JJ and Morris CP. 

Phrase: "Hum Mutat 2"

Phrase: ":"

Phrase: "435442,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hopwood JJ"

Phrase: "and"

Phrase: "Morris CP."
Processing 00000000.tx.273: The mucopolysaccharidoses: diagnosis, molecular genetics and treatment. 

Phrase: "The mucopolysaccharidoses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026703:Mucopolysaccharidoses [Disease or Syndrome]

Phrase: ":"

Phrase: "diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "molecular genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.274: Mol Biol Med 7: 381404, 1990.[ISI][Medline] Kahn SE, Andrikopoulos S, and Verchere CB. 

Phrase: "Mol Biol Med 7"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "381404,"

Phrase: "1990."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kahn SE,"

Phrase: "Andrikopoulos S,"

Phrase: "and"

Phrase: "Verchere CB."
Processing 00000000.tx.275: Islet amyloid a long-recognized but underappreciated pathological feature of type 2 diabetes. 

Phrase: "Islet amyloid a long-recognized"

Phrase: "but"

Phrase: "underappreciated pathological feature of type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.276: Diabetes 48: 241253, 1999.[Abstract/Free FullText] Kasinath BS, Grellier P, Choudhury GG, and Abboud SL. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "241253,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kasinath BS,"

Phrase: "Grellier P,"

Phrase: "Choudhury GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "and"

Phrase: "Abboud SL."
Processing 00000000.tx.277: Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium. 

Phrase: "Regulation of basement membrane heparan sulfate proteoglycan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
   739   C1415793:HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE [Gene or Genome]

Phrase: "perlecan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136134:perlecan [Amino Acid, Peptide, or Protein]
  1000   C1415793:PERLECAN [Gene or Genome]
  1000   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "gene expression in glomerular epithelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   767   C1861886:CELL Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by high glucose medium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
   734   C0860803:high glucose [Finding]
Processing 00000000.tx.278: J Cell Physiol 167: 131136, 1996.[CrossRef][ISI][Medline] Kisilevsky R and Fraser PE. 

Phrase: "J Cell Physiol 167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "131136,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kisilevsky R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Fraser PE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.279: Ab amyloidogenesis: unique or variation on a systemic theme? 

Phrase: "Ab amyloidogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "unique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "or"

Phrase: "variation on a systemic theme?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.280: Crit Rev Biochem Mol Biol 32: 361404, 1997.[Abstract] Lacy PE and Kostianovsky M. 

Phrase: "Crit Rev Biochem Mol Biol 32"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   799   C2347961:Rev. [Professional or Occupational Group]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "361404,"

Phrase: "1997."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lacy PE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Kostianovsky M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: Method for the isolation of intact islets of Langerhans from the rat pancreas. 

Phrase: "Method for the isolation of intact islets of Langerhans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "from the rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.282: Diabetes 16: 3539, 1967.[ISI][Medline] Malmgren H, Carlberg B, Pettersson U, and Bondeson M. 

Phrase: "Diabetes 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "3539,"

Phrase: "1967."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Malmgren H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carlberg B,"

Phrase: "Pettersson U,"

Phrase: "and"

Phrase: "Bondeson M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: Identification of an alternative transcript from the human iduronate-2-sulfatase (IDS) gene. 

Phrase: "Identification of an alternative transcript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "from the human iduronate-2-sulfatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0020814:Iduronate 2-sulfatase [Amino Acid, Peptide, or Protein,Enzyme]
           Iduronate Sulfatase
   923   C1415882:IDURONATE 2-SULFATASE [Gene or Genome]
   812   C0038717:Sulfatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IDS) gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415882:IDS gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.284: Genomics 29: 291293, 1995.[CrossRef][ISI][Medline] Millart G, Froissart R, Maire I, and Bozon D. 

Phrase: "Genomics 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "291293,"

Phrase: "1995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Millart G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Froissart R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Maire I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bozon D."
Processing 00000000.tx.285: IDS transfer from overexpressing cells to IDS-deficient cells. 

Phrase: "IDS transfer from overexpressing cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "to IDS-deficient cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.286: Exp Cell Res 230: 362367, 1997.[CrossRef][ISI][Medline] Naldini L, Blomer U, Gage FH, Trono D, and Verma IM. 

Phrase: "Exp Cell Res 230"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1417055:EXP [Gene or Genome]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "362367,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Naldini L,"

Phrase: "Blomer U,"

Phrase: "Gage FH,"

Phrase: "Trono D,"

Phrase: "and"

Phrase: "Verma IM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]
Processing 00000000.tx.287: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. 

Phrase: "Efficient transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "integration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158478:Integration [Genetic Function]
  1000   C1705422:Integration [Machine Activity]

Phrase: "and"

Phrase: "sustained long-term expression of the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in adult rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "injected with a lentiviral vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726   C1720154:Inject [Functional Concept]
Processing 00000000.tx.288: Proc Natl Acad Sci USA 93: 1138211388, 1996.[Abstract/Free FullText] Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, and Trono D. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1138211388,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Naldini L,"

Phrase: "Blomer U,"

Phrase: "Gallay P,"

Phrase: "Ory D,"

Phrase: "Mulligan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gage FH,"

Phrase: "Verma IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "and"

Phrase: "Trono D."
Processing 00000000.tx.289: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. 

Phrase: "In vivo gene delivery"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0872177:gene delivery [Genetic Function]
   861   C1524066:Gene Delivery [Conceptual Entity]
   812   C0011209:Delivery [Therapeutic or Preventive Procedure]
   812   C0559563:delivery [Finding]
   812   C1705822:Delivery [Activity]

Phrase: "and"

Phrase: "stable transduction of nondividing cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1160185:transduction [Organism Function]

Phrase: "by a lentiviral vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.290: Science 272: 263267, 1996.[Abstract] Neufeld EF and Muenzer J. 

Phrase: "Science 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "263267,"

Phrase: "1996."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Neufeld EF"

Phrase: "and"

Phrase: "Muenzer J."
Processing 00000000.tx.291: The mucopolysaccharidoses. 

Phrase: "The mucopolysaccharidoses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026703:Mucopolysaccharidoses [Disease or Syndrome]
Processing 00000000.tx.292: In: The Metabolic and Molecular Bases of Inherited Disease (8th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. 

Phrase: "In"

Phrase: ":"

Phrase: "The Metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "Molecular Bases of Inherited Disease"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   760   C0178499:bases [Chemical Viewed Functionally]
   760   C1626935:Bases [Quantitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C1527178:Basis [Functional Concept]
   726 E C1874451:Basis [Pharmacologic Substance]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(8th ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "edited by Scriver CR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0201975:Cr [Laboratory Procedure]
   770   C3539604:CR [Gene or Genome]
   737   C0868955:Edit [Occupational Activity]

Phrase: "Beaudet AL,"

Phrase: "Sly WS,"

Phrase: "and"

Phrase: "Valle D."
Processing 00000000.tx.293: New York: McGraw-Hill, 2001, p. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "McGraw-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "2001,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.294: 34213452. 

Phrase: "34213452."
Processing 00000000.tx.295: Novials A, Sarri Y, Casamitjana R, Rivera F, and Gomis R. 

Phrase: "Novials"

Phrase: "A,"

Phrase: "Sarri Y,"

Phrase: "Casamitjana R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rivera F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Gomis R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: Regulation of islet amyloid polypeptide in human pancreatic islets. 

Phrase: "Regulation of islet amyloid polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in human pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.297: Diabetes 42: 15141519, 1993.[Abstract] Park K and Verchere B. 

Phrase: "Diabetes 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15141519,"

Phrase: "1993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Park K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Verchere B."
Processing 00000000.tx.298: Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. 

Phrase: "Identification of a heparin binding domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "in the N-terminal cleavage site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "of pro-islet amyloid polypeptide."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0965118:pro-islet amyloid polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   923   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   812   C2987124:PRO [Intellectual Product]
Processing 00000000.tx.299: J Biol Chem 276: 1661116616, 2001.[Abstract/Free FullText] Parthasarathy N, Gotow LF, Bottoms JD, Obunike JC, Naggi A, Casu B, Goldberg IJ, and Wagner WD. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1661116616,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Parthasarathy N,"

Phrase: "Gotow LF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416933:LF [Gene or Genome]
   861   C2986618:LF [Gene or Genome]

Phrase: "Bottoms JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Obunike JC,"

Phrase: "Naggi A,"

Phrase: "Casu B,"

Phrase: "Goldberg IJ,"

Phrase: "and"

Phrase: "Wagner WD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019202:WD [Disease or Syndrome]
   861   C0332135:WD [Qualitative Concept]
   861   C1862191:WD [Intellectual Product]
   861   C3538902:WD [Gene or Genome]
Processing 00000000.tx.300: Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells. 

Phrase: "Influence of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "on production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "N-sulfation of heparan sulfate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597538:Sulfation [Phenomenon or Process]

Phrase: "in cultured adipocyte cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.301: Mol Cell Biochem 213: 19, 2000.[CrossRef][ISI][Medline] Potter-Perigo S, Hull RL, Tsoi C, Braun KR, Andrikopoulos S, Teague J, Verchere CB, Kahn SE, and Wight TN. 

Phrase: "Mol Cell Biochem 213"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "19,"

Phrase: "2000."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Potter-Perigo S,"

Phrase: "Hull RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Tsoi C,"

Phrase: "Braun KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Andrikopoulos S,"

Phrase: "Teague J,"

Phrase: "Verchere CB,"

Phrase: "Kahn SE,"

Phrase: "and"

Phrase: "Wight TN."
Processing 00000000.tx.302: Proteoglycans synthesized and secreted by pancreatic islet -cells bind amylin. 

Phrase: "Proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "secreted by pancreatic islet -cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   845   C0734999:Pancreatic islet cell [Cell]
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           Pancreatic islet
   773 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C1327616:Secreted [Cell Function]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.303: Arch Biochem Biophys 413: 182190, 2003.[CrossRef][ISI][Medline] Rohrbach DH, Hassell JR, Kleinman HK, and Martin GR. 

Phrase: "Arch Biochem Biophys 413"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "182190,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rohrbach DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Hassell JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Kleinman HK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "and"

Phrase: "Martin GR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]
Processing 00000000.tx.304: Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. 

Phrase: "Alterations in the basement membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544993:Basement membrane alteration [Cell or Molecular Dysfunction]
   781   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "(heparan sulfate) proteoglycan in diabetic mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0062503:Heparan Sulfate Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   790   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   753   C0033692:Proteoglycan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C2327880:Heparan [Biologically Active Substance]
   753   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.305: Diabetes 31: 185188, 1982.[Abstract] Schnell AH and Borg LAH. 

Phrase: "Diabetes 31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "185188,"

Phrase: "1982."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schnell AH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "and"

Phrase: "Borg LAH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0238705:LAH [Anatomical Abnormality,Disease or Syndrome]
   861   C1427484:LAH [Gene or Genome]
   861   C1842839:LAH [Disease or Syndrome]
Processing 00000000.tx.306: Lysosomes and pancreatic islet function: glucose-dependent alterations of lysosomal morphology. 

Phrase: "Lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "pancreatic islet function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0597166:pancreatic islet function [Organ or Tissue Function]
   913   C0232786:Pancreatic function [Organ or Tissue Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "glucose-dependent alterations of lysosomal morphology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0544948:Lysosome Alterations [Cell or Molecular Dysfunction]
   731   C1260954:Morphologic alteration [Anatomical Abnormality]
   719   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.307: Cell Tissue Res 239: 537545, 1985.[ISI][Medline] Snow AD and Wight TN. 

Phrase: "Cell Tissue Res 239"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007634:Cell [Cell]
   812   C0040300:Tissue [Tissue]
   812   C1269647:Cell [Cell]
   812   C1547928:Tissue [Intellectual Product]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "537545,"

Phrase: "1985."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Snow AD"

Phrase: "and"

Phrase: "Wight TN."
Processing 00000000.tx.308: Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. 

Phrase: "Proteoglycans in the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other amyloidoses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidoses [Disease or Syndrome]
Processing 00000000.tx.309: Neurobiol Aging 10: 481497, 1989.[CrossRef][ISI][Medline] Timms KM, Lu F, Shen Y, Pierson CA, Muzny DM, Gu Y, Nelson DL, and Gibbs RA. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "10"

Phrase: ":"

Phrase: "481497,"

Phrase: "1989."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Timms KM,"

Phrase: "Lu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Shen Y,"

Phrase: "Pierson CA,"

Phrase: "Muzny DM,"

Phrase: "Gu Y,"

Phrase: "Nelson DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "Gibbs RA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]
Processing 00000000.tx.310: 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfatase locus. 

Phrase: "130 kb of DNA sequence"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "two new genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "a regional duplication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332597:Duplication [Functional Concept]
   861   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "distal to the human iduronate-2-sulfatase locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.311: Genome Res 5: 7178, 1995.[Abstract] Verchere CB, Andrikopoulos S, D'Alessio DA, O'Brien KB, Wight TN, Snow AD, Olin KL, and Khan SE. 

Phrase: "Genome Res 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017428:Genome [Gene or Genome]
   827   C2338314:Genome [Conceptual Entity]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "7178,"

Phrase: "1995."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Verchere CB,"

Phrase: "Andrikopoulos S,"

Phrase: "D'"

Phrase: "Alessio DA,"

Phrase: "O'Brien KB,"

Phrase: "Wight TN,"

Phrase: "Snow AD,"

Phrase: "Olin KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "and"

Phrase: "Khan SE."
Processing 00000000.tx.312: Role of apolipoprotein E and perlecan in islet amyloid formation in transgenic mice expressing human islet amyloid polypeptide (Abstract). 

Phrase: "Role of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "perlecan in islet amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0136134:perlecan [Amino Acid, Peptide, or Protein]
   760   C1415793:PERLECAN [Gene or Genome]
   760   C2987155:Perlecan [Amino Acid, Peptide, or Protein]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "human islet amyloid polypeptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
   923   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0086418:Human [Human]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.313: Diabetes 47, Suppl 1: A30, 1998. 

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Suppl 1"

Phrase: ":"

Phrase: "A30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416178:A30 [Gene or Genome]

Phrase: "1998."
Processing 00000000.tx.314: Watson JD, Lander DA, and Selkoe JD. 

Phrase: "Watson JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Lander DA,"

Phrase: "and"

Phrase: "Selkoe JD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]
Processing 00000000.tx.315: Heparin binding properties of the amyloidogenic peptides Ab and amylin. 

Phrase: "Heparin binding properties of the amyloidogenic peptides Ab"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "amylin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:Amylin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:AMYLIN [Gene or Genome]
Processing 00000000.tx.316: J Biol Chem 272: 3131731624, 1997. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3131731624,"

Phrase: "1997."
Processing 00000000.tx.317: Westermark P, Engstrm U, Westermark GT, Johnson KH, Permerth J, and Betsholtz C. 

Phrase: "Westermark P,"

Phrase: "Engstrm U,"

Phrase: "Westermark GT,"

Phrase: "Johnson KH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: "Permerth J,"

Phrase: "and"

Phrase: "Betsholtz C."
Processing 00000000.tx.318: Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. 

Phrase: "Islet amyloid polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0063684:Islet Amyloid Polypeptide [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:ISLET AMYLOID POLYPEPTIDE [Gene or Genome]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(IAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063684:IAPP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1415831:IAPP [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "pro-IAPP immunoreactivity in human islets of Langerhans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.319: Diabetes Res Clin Pract 7: 219226, 1989.[ISI][Medline] Westermark P, Wernstedt C, Wilander E, and Sletten K. 

Phrase: "Diabetes Res Clin Pract 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C1315013:CLIN [Intellectual Product]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "219226,"

Phrase: "1989."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Westermark P,"

Phrase: "Wernstedt C,"

Phrase: "Wilander E,"

Phrase: "and"

Phrase: "Sletten K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.320: A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril protein in the endocrine pancreas. 

Phrase: "A novel peptide in the calcitonin gene-related peptide family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "as an amyloid fibril protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the endocrine pancreas."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0022131:Pancreas, Endocrine [Body Part, Organ, or Organ Component]
  1000   C1283884:Endocrine pancreas [Body Part, Organ, or Organ Component]
   861   C0014136:Endocrine [Body System]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C0521425:Endocrine [Functional Concept]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.321: Biochem Biophys Res Commun 140: 827831, 1986.[ISI][Medline] Wilson PJ, Meaney CA, Hopwood JJ, and Morris CP. 

Phrase: "Biochem Biophys Res Commun 140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "827831,"

Phrase: "1986."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilson PJ,"

Phrase: "Meaney CA,"

Phrase: "Hopwood JJ,"

Phrase: "and"

Phrase: "Morris CP."
Processing 00000000.tx.322: Sequence of the human iduronate-2-sulfatase (IDS) gene. 

Phrase: "Sequence of the human iduronate-2-sulfatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "(IDS) gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1415882:IDS gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.323: Genomics 17: 773775, 1993.[CrossRef][ISI][Medline] Wilson PJ, Morris CP, Anson DS, Occhodoro T, Bielicki J, Clements PR, and Hopwood JJ. 

Phrase: "Genomics 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "773775,"

Phrase: "1993."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilson PJ,"

Phrase: "Morris CP,"

Phrase: "Anson DS,"

Phrase: "Occhodoro T,"

Phrase: "Bielicki J,"

Phrase: "Clements PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "and"

Phrase: "Hopwood JJ."
Processing 00000000.tx.324: Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. 

Phrase: "Hunter syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026705:Hunter's Syndrome [Disease or Syndrome]
  1000   C1415882:HUNTER SYNDROME [Gene or Genome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0239971:HUNTER [Professional or Occupational Group]

Phrase: ":"

Phrase: "isolation of an iduronate-2-sulfatase cDNA clone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "analysis of patient DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0200898:DNA analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.325: Proc Natl Acad Sci USA 87: 85318535, 1990.[Abstract] Young DI, Ailles L, Narindrasorasak S, Tan R, and Kisilevsky R. 

Phrase: "Proc Natl Acad Sci USA 87"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "85318535,"

Phrase: "1990."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Young DI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Ailles L,"

Phrase: "Narindrasorasak S,"

Phrase: "Tan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kisilevsky R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.326: Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. 

Phrase: "Localization of the basement membrane heparan sulfate proteoglycan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]
   704   C1415793:HEPARAN SULFATE PROTEOGLYCAN OF BASEMENT MEMBRANE [Gene or Genome]

Phrase: "in islet amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits in type II diabetes mellitus."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0441730:Type II [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C0333562:Deposit [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.327: Arch Pathol Lab Med 116: 951954, 1992.[ISI][Medline] This Article Abstract Full Text (PDF) All Versions of this Article: 287/5/E983 most recent 00528.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Coronado-Pons, I. 

Phrase: "Arch Pathol Lab Med 116"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0022877:Lab [Manufactured Object,Organization]
   804   C0230467:arch [Body Location or Region]
   804   C0741204:ARCH [Body Space or Junction]
   748 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   721 E C0587081:Labs [Finding]

Phrase: ":"

Phrase: "951954,"

Phrase: "1992."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "287/5/E983 most recent 00528.2003v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1706852:Article [Intellectual Product]

Phrase: "by Coronado-Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0032639:Pons [Body Part, Organ, or Organ Component]
   861   C1280999:Pons [Body Part, Organ, or Organ Component]
   827 E C1418754:PON [Gene or Genome]
   827 E C1709588:PON [Mammal]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.328: Articles by Gomis, R. 

Phrase: "Articles by Gomis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: Articles citing this Article PubMed PubMed Citation Articles by Coronado-Pons, I. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Coronado-Pons,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.330: Articles by Gomis, R. 

Phrase: "Articles by Gomis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.331: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Visit Other APS Journals Online Copyright  2004 by the American Physiological Society.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "Visit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Visit [Behavior]
  1000   C1512346:visit [Health Care Activity]
  1000   C2826704:VISIT [Intellectual Product]

Phrase: "Other APS Journals Online Copyright  2004 by the American Physiological Society."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0009993:Copyright [Intellectual Product]
   738   C0037455:society [Organization]
   738   C0162443:journals [Intellectual Product,Manufactured Object]
   738   C0205394:Other [Qualitative Concept]
   738   C0205463:Physiological [Functional Concept]
   738   C0596070:American [Population Group]
   738   C1552856:copyright [Idea or Concept]

